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This thesis reports a series of studies in which 
I have examined some facets of hypertension. The 
pathophysiology of hypertension has been investigated from 
the point of view of disordered sympathetic nervous function. 
The level of excretion in urine of the chemical mediator, 
noradrenaline, has been used as an index of sympathetic 
nervous activity. The possibility has been considered 
that certain subgroups of hypertensive subjects may have 
an increased level of sympathetic activity at rest, or show 
an exaggerated sympathetic responsiveness to physiological 
stimuli such as change in posture, and mental activity.
The potential pathogenicity of such an overactivity 
of the sympathetic nervous system in hypertension has been 
considered from the point of view of possible direct and 
indirect effects on blood pressure. The possibility of 
a direct relationship between sympathetic nervous activity 
and blood pressure in hypertension has been investigated 
by studying, in parallel, noradrenaline and blood pressure 
levels at rest, and with stimulation of the sympathetic 
nervous system. The possibility of indirect effects of 
the sympathetic system on blood pressure has been 
investigated by studying the relationship of sympathetic 
activity to the level of the enzyme, renin, in blood 
plasma. Renin is produced principally by the kidney, and 
influences blood pressure through its effect on body salt 
and blood volume.
The clinical significance of overactivity of the 
sympathetic nervous system has been considered from 2 points
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of view. First, the prevalence in a hypertensive population 
of symptoms suggestive of sympathetic overactivity has been 
studied, and the relationship of symptoms to assessed levels 
of sympathetic activity, and to other factors, such as 
anxiety, has been investigated. Second, a clinical trial 
of a drug that selectively interferes with a specific 
receptor of the sympathetic nervous system has been carried 
out, in order to determine whether the therapeutic response 
to the drug, in terms of lowering of blood pressure, is 
related to the level of sympathetic nervous activity in 
hypertension.
The introductory section of this thesis will review:
1. The variability of blood pressure in essential 
hypertension, and the possibility that repeated, 
inappropriately large blood pressure responses, to 
events which affect sympathetic nervous system 
activity, may lead eventually to sustained elevation 
of blood pressure.
2. Evidence of changed sympathetic nervous system activity 
in some hypertensive subjects as shown by altered 
secretion of the neurotransmitter, noradrenaline.
3. The incidence of clinical symptoms suggestive of 
sympathetic overactivity in patients with essential 
hypertension, and the implications of this in the 
differential diagnosis of hypertension.
4. The role of the sympathetic nervous system, and other 
factors, in controlling the release of renin.
Clinical trials of drugs that block the 3-adrenergic 
receptors of the sympathetic nervous system, and hence
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3.
lower blood pressure by mechanisms related to reduced 
sympathetic activity.
I. VARIABILITY OF BLOOD PRESSURE.
Spontaneous Variability of Blood Pressure
Only since the development of techniques for continuous 
automatic or semi-automatic measurement of BP (Richardson 
et al. , 1964) has it been possible to study the spontaneous 
variability of BP in the absence of an observer. Two forms 
of variation in BP occur? large diurnal changes, BP being 
at its lowest during sleep, and short-term pressor peaks 
related to such things as physical activity and emotion.
The spontaneous variability of BP in hypertensive and 
normotensive subjects has been compared in several studies 
(Richardson et al. , 1964; Bevan et al., 1969). Indices 
used have been the range of blood pressures, systolic and 
diastolic during a 24-hour period, which is predominantly 
a measure of the diurnal change in BP, and the "undulation 
index" (Bevan et al. , 1969) or similar computation, as 
a measure of short-term variability. From the hospital- 
based studies of Richardson et al. (1964) and Bevan et al. 
(1969), it would appear that both the range and short-term 
variability of BP are greater in hypertensive patients than 
in subjects with normal blood pressure, and that among 
essential hypertensives, the range and variability is 
greatest in borderline hypertension, least in malignant 
hypertension, and intermediate in mild to moderately severe 
sustained hypertension. A contrary finding, however, has 
been reported by Sokolow et al. (1966), in a large study 
which differed in design from the British studies in that
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BP was monitored during the patients' usual routines of 
work. In this setting, variability of BP in hypertensive 
patients was found to be unrelated to the grade of severity 
of the hypertensive disease.
Blood Pressure Responses to Pressor Stimuli
Stimuli used experimentally have included change in 
posture, "mental stress", pain (in the cold pressor test), 
and exercise. It might be anticipated that the greater 
"spontaneous" variability of BP in essential hypertension 
could, perhaps, be paralleled by a greater than normal 
responsiveness to some or all of these pressor stimuli.
(i) Head-up tilting. The cardiovascular response 
to head-up tilting is complex, and includes an increase 
in heart rate, a fall in cardiac output, an increase in 
total peripheral vascular resistance, a small rise in mean 
BP, and a fall in renal blood flow and glomerular filtration 
rate (Lee et at., 1966; Fröhlich et at., 1967). Overall, 
the response in essential hypertension is qualitatively 
and quantitatively similar to that in normal subjects, but 
the scatter in blood pressure responses is greater in 
hypertensives, ranging from a substantial BP rise, through 
to postural hypotension. Patients showing postural 
hypotension tend to have more severe hypertensive disease. 
Conversely, a greater than normal rise in BP with tilting, 
an "orthostatic hypertensive" response, tends to occur in 
subjects with borderline or mild sustained hypertension.
A large rise in total peripheral resistance is the basis 
of a supranormal BP rise with tilting (Fröhlich et at.,
1967) .
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(ii) "Mental Stress". Blood pressure rises occur 
in anxiety-provoking situations (Nestel, 1969), and even 
during quiet conversation (Ulrych, 1969) . There is an 
accompanying catecholamine response (Nestel, 1969), 
predominantly involving adrenaline (von Euler, 1964).
The blood pressure rise is primarily related to an increase 
in cardiac output (Brod, 1959; Ulrych, 1969). The BP 
response to mental stress in patients with sustained 
essential hypertension is similar to that in normal subjects 
(Brod, 1959; Ulrych, 1969). However, a greater than 
normal BP and catecholamine response to mental stress has 
been reported in borderline hypertension (Nestel, 1969) .
(iii) The Cold-Pressor Test. Early reports of 
greater than normal blood pressure rises in essential 
hypertensives stimulated by painful procedures such as the 
cold pressor test (Hines and Brown, 1932), have not been 
consistently confirmed. In contrast to the finding that 
a substantial proportion of essential hypertensives were 
hyperreactors to the cold pressor test (Hines, 1940),
Boyer et at. (1960), in a study including borderline and 
sustained hypertensives, could find no difference between 
hypertensives and normotensives in the average BP response, 
or in the proportion of hyperreactors (rise in mean BP more 
than 20 mmHg) in the 2 groups.
(iv) Exercise. With dynamic exercises, cardiac 
output rises, total peripheral resistance falls, systolic 
blood pressure rises, and diastolic blood pressure changes 
little if at all. In most published studies, the response 
in essential hypertension has been reported as
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qualitatively and quantitatively similar to that in normal 
subjects (Hamer et al. , 1967; Julius and Conway, 1968).
Hamer et al. (1967) found similar changes in BP and total 
peripheral resistance in borderline, moderate sustained, 
and severe essential hypertension.
In summary, greater than normal pressor responses 
to tilting and mental stress have been described in 
borderline hypertension. In sustained essential hyper­
tension, the response to these stimuli, and to the cold 
pressor test and dynamic exercise, are within normal limits.
The greater than normal BP rise in borderline 
hypertensives subjected to mental stress is accompanied by 
an above-average catecholamine response (Nestel, 1969).
A neural basis for the supranormal BP response to tilting 
in "orthostatic hypertensives" also is inferred, although 
increased vascular reactivity has not been excluded as the 
possible cause (Fröhlich et al. , 1967). The relationship 
of the change in urinary noradrenaline excretion on tilting 
to the blood pressure response has been assessed (Chapter 
3), to investigate further the question of sympathetic 
nervous responsiveness in patients with an orthostatic 
hypertensive response.
The Potential Pathogenicity of Repeated Pressor Responses
It is probable that an enhanced sympathetic responsive­
ness to some pressor stimuli (such as head-up tilting and 
"mental stress") may be a common accompaniment of borderline 
and early mild sustained essential hypertension, to be lost 
later if the hypertensive process becomes more severe 
(Fröhlich et al. , 1967; Nestel, 1969). The suggestion that
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this enhanced sympathetic responsiveness in borderline 
hypertension contributes to the development of sustained 
essential hypertension, and hypertensive cardiovascular 
complications, is largely speculative, as the evidence is 
both indirect and incomplete. The first line of evidence 
relates the origin of the elevated cardiac output in 
borderline hypertension to the adrenergic responsiveness, 
and traces the clinical and haemodynamic progression of 
borderline hypertension to sustained hypertension.
The second line of evidence stresses the relationship of 
the casual blood pressure (and hence reactive changes in 
BP) to morbidity in essential hypertension.
(i) The relationship of sympathetic hyperresponsive­
ness to an elevated cardiac output in borderline 
hypertension. There have been numerous reports 
documenting the existence of an elevated mean cardiac output, 
with total peripheral resistance near normal, in borderline 
essential hypertension (Eich et al., 1966; Julius and 
Conway, 1968; Conway, 1970). The cardiac output is 
elevated in only a proportion of borderline hypertensives 
(Conway, 1970) . The haemodynamic findings are in contrast 
to those of a normal or reduced cardiac output and elevated 
total peripheral resistance in severe hypertension (Bello 
et al. , 1967) . The basis of the above-average cardiac 
output is incompletely understood. However, studies on 
the effect of ß-adrenergic and parasympathetic blockade 
on cardiac output in borderline hypertension (Julius et al. , 
1971) provide some support for the concept that the 
elevated cardiac output is related to sympathetic nervous 
overactivity in combination with parasympathetic underactivity.
It is possible that a relationship between sympathetic 
activity and increased cardiac output could be mediated by 
an indirect mechanism, through retention of sodium. In 
susceptible animals, such as the partially nephrectomized 
dog (Coleman and Guyton, 1969), saline loading produces an ' 
elevation in cardiac output and blood pressure. In man, 
head-up tilting is accompanied by a marked reduction in the 
urinary excretion of sodium (Birkenhager et al., 1962).
In sympathetic hyperresponders, with oft-repeated stimulation, 
the potential may exist for retention of sodium and possibly 
resultant elevations in BP and cardiac output. Among 
hypertensives, cardiac output is highest in hyperresponders 
to tilt (Fröhlich et al. , 1967). Birkenhager et al. (1968) 
found positive correlations between resting cardiac index, 
blood volume, and variability of BP in untreated essential 
hypertensives. The acute effect of tilting on the urinary 
excretion of sodium, in hypertensives with a greater than 
normal blood pressure response to tilt, is presented in 
Chapter 4.
It is now clear that progression of borderline 
hypertension to sustained hypertension commonly occurs 
(Miall and Lovell, 1967; Heyden et al. , 1969). A tendency 
for haemodynamic status also to change, from a state of high 
cardiac output and normal total peripheral vascular resistance, 
to normal cardiac output and high peripheral resistance, has 
been documented, but the number of patients studied is small 
(Eich et al., 1966). Cross-sectional studies, on different 
grades of severity of hypertension, suggest that changes in 
haemodynamic status do occur (Fröhlich et al. , 19 70) . The 
basis of the rise in total peripheral resistance is not known.
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The concept of autoregulation of flow, which refers to 
adjustments in vascular resistance of an organ in relation 
to its perfusion, has been implicated, but may net be valid 
for the body as a whole (Coleman and Guyton, 1969).
(ii) The relationship of casual BP to morbidity in 
hypertension. It has been suggested by Smirk 
(1957) that as hypertensive patients spend much of their 
time sleeping or at rest, the "basal" blood pressure, 
measured under defined conditions of rest, may provide the 
best index of prognosis. A close relationship between 
basal BP, and both the presence of stigmata of hypertensive 
cardiovascular disease and the prognosis, has been 
demonstrated (Smirk, 1957). However Hamer (1968) has 
emphasized that in patients engaged in normal activities, the 
blood pressure load on the heart and blood vessels during 
waking hours is probably most closely represented by the 
casual BP. It might therefore be expected that the risk 
of developing hypertensive cardiovascular complications 
be related also to the level of the casual BP. This 
has been borne out in a large study by Sokolow et at. (1966), 
on patients engaged in normal routines of work, in which 
a close relationship was found to exist between the severity 
of the hypertensive disease (graded on the presence of 
hypertensive cardiovascular complications) and the average 
BP recorded continuously by indirect means.
Casual BP reflects in part reactive BP changes (Smirk, 
1957). The responsiveness of hypertensives to pressor 
stimuli might thus be expected to be a determinant of the 
level of the casual BP. Whether this is so has been little
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studied. However, the observation has been made by Hamer 
et al. (1967) that systolic blood pressure during exercise, 
in hospitalized patients some of who had a "normal" resting 
BP at the time of testing, predicted subsequent outpatient 
casual pressures.
I!. URINARY AND PLASMA LEVELS OF CATECHOLAMINES AND THEIR
METABOLITES IN ESSENTIAL HYPERTENSION.
3,4-dihydroxyl-benzyl amines (catecholamines) occur 
normally in urine (Holtz et al. , 1947). Urinary adrenaline 
has its origin in the secretions of the adrenal medulla 
(von Euler et al. , 1954(a)). Noradrenaline is the 
neurotransmitter of the sympathetic nerves (von Euler,
1946) , but is released also from the adrenal medulla (Lund, 
1951). The sympathetic nerve endings are thought to be the 
major source of circulating noradrenaline. This finds 
support in the failure of bilateral adrenalectomy to suppress 
the urinary excretion of noradrenaline (von Euler et al. , 
1957).
With the development of a sensitive method of assay of 
urinary catecholamines (Lund, 1949), the hypothesis that 
these pressor amines play an important role in the genesis 
of essential hypertension could be tested. An elevated 
total peripheral vascular resistance was a consistent finding 
in early studies on the haemodynamics in essential 
hypertension, cardiac output being within normal limits 
(Pickering, 1936; Wiggers, 1938). Greater amounts of 
noradrenaline in the urine of hypertensives than in subjects 
with normal blood pressure would be consistent with the 
hypothesis that sympathetic nervous system overactivity
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underlies the increased peripheral resistance of 
hypertension.
In several studies, mean excretion rate of 
catecholamines in essential hypertensives was no different 
from that in subjects with normal BP (Crout et at, , 1961;
Theil and Garcia, 1965), but in some investigations, 
a proportion of hypertensives were found to have an 
elevated excretion of noradrenaline (von Euler et at, , 1954; 
Goodall and Bogdonoff, 1961; Nestel and Doyle, 1968). The 
urinary excretion of catecholamines is very labile, being 
readily influenced by such factors as posture (Sundin, 1956), 
exercise (Karki, 1956), and emotion (Levi, 1963). The 
discrepancies in these findings may well have arisen in part 
from failure, in some cases, to adequately standardize the 
experimental conditions.
The major urinary metabolites of adrenaline and 
noradrenaline are 3-methoxy-4-hydroxymandelic acid (VMA), 
metadrenaline, and normetadrenaline. Normetadrenaline 
is principally derived from noradrenaline released at the 
sympathetic nerve ending, and o-methylated at the nerve 
ending, or in the liver (Wurtman, 1965). The main source 
of urinary metadrenaline is adrenaline secreted by the 
adrenal medulla, and metabolized by catechol-o-methyltrans- 
ferase in the liver and other organs (Wurtman, 1965). VMA 
is the urinary metabolite of both adrenaline and noradrenaline 
(Armstrong et at. , 19 57) , formed from the catecholamines by 
o-methylation and oxidative deamination. Most studies 
on the urinary excretion of metadrenaline, normetadrenaline, 
and VMA in hypertensives have shown the rate of excretion 
not to differ significantly from that in normotensives
12 .
(Crout et al. , 1961; Theil and Garcia, 1965; Gitlow et al., 
1960). However, Brunjes (1964) reported low urinary 
excretion of VMA and metadrenaline in essential hypertension.
Fluorimetric assays of plasma catecholamines have been 
characterized by poor reproducibility, related to a high 
plasma blank fluorescence. Recently, 2 sensitive assays 
for plasma adrenaline and noradrenaline have been developed.
In one (Valori et al. , 1970), a modification of the 
trihydroxyindole method of Lund (19 49) , the problem of 
background fluorescence has been largely overcome. The 
other makes use of a double-isotope derivative technique 
(Engelman et al. , 1970). The mean plasma catecholamine 
level, as measured by these methods, is elevated in 
essential hypertension (Engelman et al., 1970; De Quattro, 
1972) .
Interpretation of the higher plasma and urinary levels of 
noradrenaline in a proportion of essential hypertensive 
patients is difficult. In the first place, the pathogenesis 
of the blood pressure elevation certainly involves mechanisms 
more complex than a sustained vasopressor response involving 
an increase in total peripheral resistance, and mediated 
directly through the sympathetic nervous system. Populations 
of essential hypertensives are not homogeneous in 
a haemodynamic sense. Although the blood pressure 
elevation in severe sustained hypertension reflects an 
increase in total peripheral resistance, in borderline 
hypertension and mild sustained hypertension TPR is often 
normal, cardiac output being elevated (Julius and Conway,
196 8) . The primary abnormality of early hypertension may 
possibly be an elevation in cardiac output. Perhaps with
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progression of the disease to more severe forms, the 
haemodynamic pattern of a normal cardiac output and increased 
TPR, long considered typical of essential hypertension, may 
evolve (Bello et al. , 1967). Possible causes of the rise 
in TPR in severe hypertension, other than increased 
sympathetic nervous activity, include an increase in 
vascular reactivity to vasoactive agents (Doyle et al. , 1959), 
and a non-contractile impediment to blood flow (Conway, 1963).
A second major problem in the interpretation of the 
higher noradrenaline levels centres around the validity of 
plasma and urinary noradrenaline levels as an index of 
sympathetic nervous activity. This question is reviewed 
in more detail in Chapter 2. Difficulties relate 
particularly to the fact that only a small proportion of the 
noradrenaline released at sympathetic nerve endings diffuses 
into plasma; most is "inactivated" locally by reuptake into 
the nerve ending or by o-methylation (Anden et al., 1969).
In recent years, attempts have been made to classify 
essential hypertension in terms of certain physiological 
and clinical characteristics. There have been reports of 
reduced plasma volume (Tarazi et al. , 1968), low plasma 
renin activity (Jose and Kaplan, 1969) , and increased 
responsiveness of the sympathetic nervous system (Fröhlich 
et al. , 1967; Nestel, 1969). Changes in catecholamine 
production might theoretically be encountered with each 
of these. Plasma volume is reduced in phaeochromocytoma 
(Brunjes et al. , 1960) . The secretion of renin and 
noradrenaline are related through a common response to salt 
depletion and hypovolaemia (Vander, 1967). The 
relationship of urinary catecholamine excretion to plasma
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volume, responsiveness of the sympathetic nervous system, 
and renin-angiotensin status has been studied (Chapter 7).
HI. ESSENTIAL HYPERTENSION WITH "HYPERKINETIC CIRCULATION".
Symptoms of episodic palpitations, sweating, and 
anxiety in patients with an elevated blood pressure should 
suggest the possible diagnosis of phaeochromocytoma. But 
the majority of hypertensive patients with such symptoms, 
when adequately investigated, prove not to have 
a catecholamine-secreting tumour. Significant discomfort 
related to recurrent cardiac irregularities, or rapid, 
forceful cardiac action, occurring without an obvious 
precipitant, or in relation to exercise or emotion, is 
a common complaint in these patients (Fröhlich, 1971). 
Findings reported in these hypertensives with "hyperkinetic 
circulation" include an elevated resting pulse rate and 
cardiac output (Fröhlich et al. , 1969), and an increased 
sensitivity of the ß-adrenoceptors of the heart to infused 
isoprenaline, in hypertensives with "hyperdynamic 
3-adrenergic disease" (Fröhlich et al. , 1969).
The term "hyperkinetic circulation" has found wide 
usage in the literature on essential hypertension, but the 
meaning remains ill-defined and confusing. Symptomatology, 
physical findings, and haemodynamic findings have been used 
to differing extents by different authors in categorizing 
the syndrome. Cardiac symptoms, a high resting pulse rate 
and an elevated cardiac output have all been emphasized 
(Julius et al. , 1971; Fröhlich, 1971) . The limits of the 
syndrome are not well defined, and the relationship of 
hypertension with "hyperkinetic circulation" to
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"neurocirculatory asthenia" (Hurst and Logue, 1966), and to 
the "hyperkinetic heart syndrome" (Gorlin, 1962), in which 
systolic blood pressure is commonly elevated, is not clear.
That hypertension with hyperkinetic circulation 
constitutes a distinct subgroup of essential hypertension 
is open to question. An elevated resting pulse rate and 
cardiac output have been reported in borderline and mild 
sustained essential hypertension in the absence of cardiac 
symptoms (Eich et al. , 19 62) . Further, it is well known 
that essential hypertension is commonly asymptomatic at 
the time of diagnosis, symptoms developing later in relation 
to anxieties induced by knowledge of the diagnosis and 
possible complications of hypertension (Pickering, 1972).
The symptoms described in hyperkinetic circulation are, 
in fact, non-specific, and similar to those commonly found 
in anxiety states (Hurst and Logue, 1966).
The prevalence of symptoms of hyperkinetic circulation 
in a consecutive series of patients with untreated 
essential hypertension has been studied (Chapter 8), and 
the relationship of these symptoms to levels of anxiety and 
neuroticism, and to the responsiveness of the sympathetic 
nervous system investigated.
iv. THE control of renin rel ease.
Mechanisms Controlling the Secretion of Renin
Controlling influences on the secretion of renin have 
recently been reviewed by Davis (1971). Current evidence 
indicates that an intrarenal baroreceptor, the macula densa, 
the renal sympathetic nerves, and circulating catecholamines 
may all have an important role. The predominant system
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promoting a renin response in a particular situation is 
dependent on the experimental conditions.
The "baroreceptor hypothesis" views the sensor as the 
juxtaglomerular cells of the afferent arteriole, these cells 
responding to a decrease in stretch with an increase in the 
secretion of renin (Skinner et al. , 1964). Changes in 
renal arterial pressure, blood volume, and renal interstitial 
pressure, and vasodilator and vasoconstrictor drugs, could 
all operate at this level. Attempts have been made to 
isolate the effects of the intrarenal baroreceptor by 
studying the non-filtering, denervated kidney (Blaine et al. , 
1970(a), 1970(b)). With this model, renin responses to 
haemorrhage and aortic constriction have been demonstrated 
in the dog which could not have been mediated through the 
macula densa or sympathetic nerves.
The "macula densa theory" views the macula densa 
influencing renin secretion by acting as a sodium sensor. 
There is dispute over what constitutes an adequate stimulus 
to the macula densa. Vander and Carlson (1969) have 
stressed an inverse relationship between the sodium load 
delivered to the distal renal tubule and renin release.
Cooke et al. (1970) have presented evidence supporting 
a direct relationship between intraluminal sodium 
concentration in the distal tubules and renin release. 
Confusion in this area may well have arisen from the 
extensive use of diuretics as a stimulus. The response 
to diuretics is complex, and may involve sodium depletion, 
hypovolaemia, altered tubular sodium concentrations, 
changes in intrarenal vascular resistance, and possibly 
direct effects on the macula densa (Vander and Carlson,
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1969; Cooke et al. , 1970; Birtch et al. , 1967).
Evidence for the role of the renal sympathetic nerves 
in the release of renin has come from several sources.
Vander (1965) produced release of renin by electrical 
stimulation of renal nerves in dogs, and by infusion of 
catecholamines. The renin response to sodium depletion in 
dogs is abolished by renal denervation (Mogil et al. , 1969 ). 
Gordon et al. (i967) noted an absent renin response to 
upright posture and sodium depletion in a patient with 
autonomic degeneration. Renin secretion accompanies the 
endogenous release of catecholamines, such as in 
hypoglycaemia (Otsuka et al. , 1970).
Effects of the Sympathetic Nervous System and Circulating 
Catecholamines on Renin Secretion
(i) Circulating catecholamines. Circulating 
catecholamines can induce secretion of renin. This has 
been shown in the dog following catecholamine infusions 
(Vander, 1965), and release of endogenous catecholamines, 
in response to insulin hypoglycaemia (Otsuka et al. , 1970). 
Assaykeen et al. (1970) reported the renin response to 
insulin hypoglycaemia to be abolished by the ß-adrenergic 
receptor blocker, propanolol, but to be little influenced 
by the a-adrenergic blocking agent, phenoxybenzamine. 
Isoprenalme leads to small increases in renin secretion 
in the normal dog (Winer et al. , 1971) and to a large renin 
response in dogs with experimental renovascular stenosis. 
The response appears to be independent of changes in 
arterial blood pressure and renal blood flow (Ayers et al. , 
1969). The mechanism of the renin response to circulating
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adrenaline and noradrenaline has been studied in the dog 
using the non-filtering kidney model (Johnson et al. , 1971) . 
Renin secretion produced by an infusion of adrenaline 
appears to be related to a reduction in renal blood flow, 
and is abolished by the vasodilator, papaverine. The 
effect of circulating noradrenaline seems to be independent 
of change in renal blood flow.
(ii) Renal sympathetic nerves. Renin secretion 
follows electrical stimulation of the renal nerves (Vander, 
1965), and activation of the sympathetic nervous system by 
such noradrenergic stimuli as head-up tilting (Oparil et al. 
1970). Michelakis and McAllister (1972) noted the renin 
response to upright posture to be markedly reduced by 
propanolol, but not affected by phenoxybenzamine. Winer
et al. (1969) found the increase in PRA produced by upright
posture and diazoxide to be reduced by both propranolol 
and the a-blocker phentolamine.
(iii) Adrenergic receptors subserving renin release. 
There is considerable confusion in the published work on 
renin release as to whether renin secretion produced by 
sympathetic nervous stimulation and circulating 
catecholamines is classifiable in terms of classical 
adrenergic receptor theory. This confusion probably 
derives in part from the fact that there may be direct 
effects, on the juxtaglomerular cells (Michelakis et al., 
1969), and indirect effects secondary to changes in blood 
pressure, renal vascular resistance, glomerular filtration 
rate, and filtered load of sodium passing to the distal 
renal tubules (Johnson et al. , 1971). A second factor may 
be the use of phentolamine (Winer et al. , 1969) as an
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a-blocker. This drug has independent effects as 
a vasodilator (Nickerson, 1965) , and might influence renin 
release independently of its a-blocking activity, by reducing 
renal vascular resistance. The work of Michelakis and 
McAllister (1972), and of Assaykeen et al. (1970) suggests 
that ß-receptors mediate the major component of the renin 
response to sympatho-adrenomedullary activation, at least 
for the stimuli of upright posture and hypoglycaemia. But 
the matter is not entirely settled (Winer et al. , 1971).
Low-Renin Essential Hypertension
Plasma renin activity is suppressed and unresponsive in 
primary aldosteronism. The place of measurement of the 
plasma renin level in the investigation of cases of 
suspected primary aldosteronism has been stressed (Conn et 
al. , 1964). But it has become clear that in approximately 
20% of essential hypertensives PRA is low during recumbency, 
and rises with stimuli such as upright posture less than in 
normal subjects (Channick et al. , 1969). An elevated 
aldosterone secretion rate is not the basis of the suppressed 
renin release in these patients; in a series of 300 
unselected essential hypertensives, Crane et al. (1972) 
found only 1 in 33 patients with low renin levels had primary 
aldosteronism.
Although aldosterone levels are normal in low-renin 
essential hypertension, there is a large body of indirect 
evidence supporting mineralocorticoid excess as the basis 
of the disorder. In patients with low-renin essential 
hypertension, an elevated total body exchangeable sodium 
(Woods et al. , 1969) and expanded extracellular fluid
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volume (Jose and Kaplan, 1969) have been reported. 
Aminoglutethemide, an inhibitor of adrenal steroidogenesis, 
lowers BP more in these patients than in other essential 
hypertensives (Woods et al. , 1969). Control of the 
elevated BP by a high dose of spironolactone is achieved in 
a higher proportion of patients with renin unresponsive 
hypertension than in hypertensives with normal or elevated 
PRA (Crane and Harris, 1970). An active search for sodium- 
retaining hormones other than aldosterone as a possible basis 
of the disorder continues. Increased secretion of 
18-hydroxydesoxycorticosterone has been reported in certain 
patients with hypertension (Melby et al. , 1971). These 
patients have suppressed plasma renin levels, and respond to 
high doses of spironolactone with normalization of BP. 
However, desoxycorticosterone (Woods et al., 1969) and 
18-hydroxydesoxycorticosterone (Spark and Melby, 1971) levels 
have been found to be normal in low-renin hypertension. The 
possibility of an undiscovered steroid remains.
Although there is strong evidence that the sympathetic 
nervous system plays an important role in renin release 
(Gordon et al. , 1967), sympathetic activity in low-renin 
hypertension has been little studied. Crane et al. (1972)
have reported low urinary catecholamine levels in this 
disorder, but suppression of catecholamines could be 
incidental to the abnormality in sodium status in these 
individuals with an increased total body exchangeable 
sodium (Gordon et al. , 1967), and not causally related to 
the low renin level. The finding of Crane and associates 
contrasts with that of Jose et al. (1970), who noted PRA 
to be unrelated to urinary catecholamine levels. This
21.
latter group reported also a diminished renin response to 
noradrenaline infusion in 4 patients with renin unresponsive 
hypertension, and raised queries as to the sensitivity to 
catecholamines in this condition.
Underactivity of the sympathetic nervous system could be 
related to the phenomenon of low-renin essential hypertension. 
Orthostatic hypotensives, with postural hypotension, and 
a reduced rise in total peripheral vascular resistance on 
tilting (Fröhlich et at., 1967), could possibly prove to be 
renin unresponsive. This possibility has been investigated 
by measuring the plasma renin activity at rest, and the PRA, 
blood pressure, and catecholamine response to tilting in 
subjects with untreated essential hypertension (Chapter 4).
V. THE ANTI-HYPERTENSIVE ACTION OF 6-ADRENERGIC BLOCKING
DRUGS.
Apart from diuretics, most drugs currently used in the 
treatment of hypertension diminish sympathetic nervous 
system activity, usually through effects on ganglionic 
transmission, or more commonly by inhibiting catecholamine 
uptake, synthesis, storage or release. In general these 
drugs interfere with the innervation of arterioles and veins, 
thereby blunting the peripheral vascular responses to change 
in posture, and accentuating orthostatic fluctuations in BP.
ß-adrenergic blockers are exceptional in this respect 
and several studies, mainly of propranolol, have 
demonstrated satisfactory control of moderate hypertension, 
even in the supine position and without undesirable 
hypotension in relation to exercise or the upright posture 
(Prichard, 1970; Zacharias, 1971). The precise manner 
in which propranolol reduces blood pressure in hypertension
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is uncertain. Its spectrum of activity includes blockade 
of the ß^-adrenoceptors of the heart, and extends to the 
ß^-receptors which mediate smooth muscle relaxation in 
bronchi, the coronary circulation, and the peripheral 
circulation (Barrett, 1971). From acute studies with 
propranolol, an antihypertensive effect of chronic oral 
dosage might not be anticipated. The immediate haemodynamic 
response to intravenous administration of propranolol is 
a fall in cardiac output, a rise in total peripheral vascular 
resistance, and no appreciable change in blood pressure 
(Ulrych et al. , 1968). With long-term oral dosage there 
is a reduction in arterial pressure, heart rate, and cardiac 
output, and a rise in total peripheral resistance (Fröhlich 
et al., 1968). Other effects of long-term oral dosage 
include reductions in plasma volume (Tarazi et al. , 1971) 
and plasma renin activity (Michelakis and McAllister, 1972).
It has variously been suggested that the BP-lowering 
effect of propranolol may be related to the reduction in 
cardiac output, to the lower plasma renin activity, or to 
central effects on noradrenergic neurones (Fröhlich et al., 
1970; Nayler, 1972). Although cardiac output and PRA are 
lowered by propranolol, it remains unproven that either is 
a major BP-lowering mechanism. A recent finding by Tarazi 
and Dustan (1972), in a group of 52 hypertensives treated 
with propranolol, was that the fall in BP was unrelated to 
the degree of reduction in cardiac output. The majority 
of these patients had cardiac output reduced by the drug, 
but in most this fall in cardiac output was offset in part 
by a rise in total peripheral resistance. TPR rose in 
the group as a whole, but to a differing extent in individual
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patients. The patients with the best response in blood 
pressure were those with the smallest rises in TPR.
Essential hypertensives differ widely in their 
sensitivity to propranolol, dose requirements ranging from 
perhaps 0.1 g to 3.0 g daily (Prichard, 1970; Zacharias,
1971) . Attempts to predict the BP-lowering effect of 
propranolol in individual hypertensive patients have, on 
the whole, not been successful. An exception is in 
essential hypertensives with "hyperdynamic ß-adrenergic 
disease" (Fröhlich et al. , 1969), in whom a raised blood 
pressure is associated with cardiac symptoms, such as 
palpitations, and excessive sensitivity to infused ß-agonist 
can be demonstrated. Both cardiac symptoms and elevated
BP respond to a relatively low dose of propranolol in these 
patients. Initial impressions (Fröhlich et al. , 1970) 
that among essential hypertensives, those with an elevated 
cardiac output are most sensitive to the BP-lowering effect 
of propranolol, have not been confirmed (Tarazi and Dustan,
1972) .
The antihypertensive activity of some other 
ß-adrenoceptor blockers has been evaluated. Practolol 
(Prichard et al. , 1971), oxprenolol (Waal-Manning, 1970) and 
prindolol (Waal-Manning, 1970) have all been shown to lower 
arterial pressure in essential hypertension. The 
antihypertensive activity of these agents relative to that 
of propranolol is uncertain. In the only comparative trial, 
(Waal-Manning, 1970), propranolol, practolol, oxprenolol, 
and prindolol were found to be of similar potency, but in 
this trial a 2-week crossover design was used, and 
a residual effect on blood pressure from the previous
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ß-adrenergic blocker may well have been present when 
a particular drug was being evaluated.
Practolol differs from propranolol in its spectrum of 
action. Its $-adrenoceptor blocking activity is confined 
largely to ß^-receptors, so that it is relatively 
cardioselective (Barrett, 1971). It has predominantly 
a negative chronotropic effect on the heart, with a minimal 
negative inotropic effect (Finegan et al. , 1972) . Blocking 
activity for ß2~receptors, which mediate smooth muscle 
relaxation in the bronchi, coronary vessels, and peripheral 
vascular tree, is much less than that of propranolol 
(Barrett, 1971) . The reduction in BP produced by 
propranolol is closely and inversely related to change in 
total peripheral resistance. BP falls are larger in 
patients with little or no rise in TPR (Tarazi and Dustan, 
1972). The basis of the rise in TPR is not completely 
understood. It may be reflex, and related to the 
reduction in cardiac output, or perhaps reflects peripheral 
vascular ß2_adrenoceptor blockade. As practolol has little 
ß2~adrenoceptor blocking activity and changes in TPR with 
long-term oral dosage are minimal (Bodem et al., 1971), the 
antihypertensive activity of practolol might be anticipated 
to be at least equal to that of propranolol.
Propranolol in low dosage has been used to control the 
elevation of blood pressure in hypertensives with 
"hyperdynamic ß-adrenergic disease", in whom it has been 
suggested there is increased sensitivity of 
ß-adrenoceptors to catecholamines (Fröhlich et al. , 1969).
It seemed possible that differences in the individual 
sensitivity of hypertensive patients to the BP-lowering
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effects of 8-adrenergic blocking drugs might be related to 
differences in reflex activity of the sympathetic nervous 
system. This possibility has been investigated in a drug 
trial in which practolol was used as the sole antihypertensive 
agent, and the relationship between fall in blood pressure on 
the drug, and reflex sympathetic response to tilting prior to 




The experimental designs of individual studies are 
described in subsequent Chapters. In this Chapter, general 
aspects of methodology are considered.
ESTIMATION OF SYMPATHETIC NERVOUS ACTIVITY
The events following sympathetic nerve stimulation 
have been reviewed by Anden et al. (1969). Stimulation of
adrenergic nerves causes quantal release of noradrenaline, 
accompanied by proportional amounts of other granular 
components, such as adenine nucleotides and the enzyme 
dopamine ß-hydroxylase. The released noradrenaline 
produces post-synaptic excitation, and is "inactivated" by 
several different mechanisms, including reuptake by the 
membrane pump, diffusion into the blood, and to some extent 
local enzymatic destruction by catechol-O-methyltransferase 
(COMT). Plasma levels of noradrenaline are determined 
by the amount of transmitter released, the activity of the 
local mechanisms of neuronal reuptake and enzymatic 
degradation by COMT, the rate of diffusion into the blood, 
and the rate of extraction of noradrenaline from plasma.
The degree to which the plasma noradrenaline level reflects 
the rate of noradrenaline release depends on the 
circumstances. If the inactivating mechanisms are impaired, 
such as by blocking the neuronal pump, diffusion of 
noradrenaline into the blood will be enhanced, and plasma 
levels of the amine will more closely reflect the rate of 
noradrenaline release. Under conditions of increased 
blood flow, such as during hard muscular exercise, diffusion
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of noradrenaline into the blood is increased, and the 
plasma noradrenaline more faithfully reflects the rate of 
noradrenaline release (Anden et al. , 1969).
Under less ideal conditions, this relationship no 
doubt holds less closely, but there is good evidence that 
the plasma (and urinary) level of noradrenaline is a 
qualitatively valid if quantitatively inexact index of 
sympathetic nervous activity. Patients with autonomic 
degeneration excrete reduced amounts of noradrenaline in 
the urine (Goodall et al. , 1968). When a sympathetic 
nerve trunk is electrically stimulated the rate of 
noradrenaline release into venous blood is directly 
related to the frequency of nerve discharge (Brown and 
Gillespie, 1957). Plasma and urinary noradrenaline levels 
rise in response to head-up tilting, and the magnitude of 
the response is directly related to the angle of tilting 
(Sundin, 1956; Hickler et al. , 1959). It would seem 
that the change in noradrenaline level is at least a valid 
semi-quantitative index of change in sympathetic nervous 
activity.
One problem is that the relative contribution by 
sympathetic nerves from different sites to the total 
noradrenaline plasma pool cannot be determined. This 
applies to head-up tilting, which has been used as an 
adrenergic stimulus in this work. Since adrenalectomized 
patients have been shown to have a normal noradrenaline 
response to tilt (von Euler and Franksson, 1957) it is 
presumed that the sympathetic nerves to arterioles are the 
major source of the noradrenaline increment. But other 




Because of very high blank fluorescence, assay systems 
for plasma catecholamines have been characterized by poor 
reproducibility. A recently described modification of the 
trihydroxyindole method, in which a concentrating step on 
an ion exchange resin has been introduced, seems to have 
overcome the problem of high background fluorescence 
(Valori et al. , 1970). The double-isotope derivative 
assay of Engelman and Portnoy (1970) is also a sensitive 
and accurate technique.
Free Urinary Catecholamines
To what extent urinary catecholamine excretion in 
man reflects plasma levels remains an open question. In 
this work, urinary noradrenaline and adrenaline excretion 
and endogenous creatinine clearance have been measured 
concurrently, and adjustment made for within-group 
differences in GFR, and for incomplete emptying of the 
bladder, as follows:
Adjusted catecholamine excretion (yg catecholamine/ 
litre of plasma cleared of creatinine) = catecholamine 
excretion (yg/min)/GFR(litre/min). As with the commonly 
adopted convention of expressing urinary catecholamines 
simply in relation to the rate of excretion of creatinine, 
the assumption is made that adrenaline and noradrenaline 
excretion is a function only of plasma levels and glomerular 
filtration, renal tubular mechanisms having no role. This 
remains unproven in man, and the evidence from animal 
experimentation is conflicting (Rennick and Pryor, 1965; 
Overy et al. , 1967). Formal clearance studies in man are
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needed to clarify this point, but until definitive information 
is available, the adjustment of catecholamine excretion 
rates for differences in GFR would seem a satisfactory 
compromise. In 32 normal subjects with a wide range of 
creatinine clearances, a close correlation was observed 
between creatinine clearance and urinary noradrenaline 
excretion; r = 0.67, p < 0.001, Fig. 2-1. Adjusted 
adrenaline and noradrenaline levels (yg catecholamine 
excreted per litre of plasma cleared of creatinine) in 
normal subjects and in patients with essential hypertension 
(Chapter 7) proved to be very similar to published plasma 
levels measured by a double-isotope derivative assay 
(Engelman and Portnoy, 1970; De Quattro, 1972).
Total Urinary Catecholamines, Vanillyl Mandelic Acid,
Normetadrenaline
For most purposes, the estimation or urinary free 
catecholamines is preferable to measuring total urinary 
catecholamines (free plus conjugated) (Crout, 1961).
Urinary excretion of the acid-labile conjugates may be 
influenced by diet (Crout and ’Sjoerdsma, 1959), contributes 
up to 60% of the total urinary noradrenaline excretion 
(Elmadjian et at, , 1956) , and gives little indication of 
the level of free noradrenaline in plasma. Urinary vanillyl 
mandelic acid (VMA) excretion has been used as an index of 
sympathetic nervous activity, and urinary VMA and total 
free catecholamine excretion correlate significantly 
(Nestel and Doyle, 1968). But VMA is partly derived from 
adrenaline, and from deamination of "firmly bound" 
noradrenaline in the nerve ending (Kopin, 1964), so it would
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be anticipated that excretion of VMA would be a less 
sensitive index of sympathetic nervous activity than 
noradrenaline excretion. There is evidence that released 
noradrenaline that diffuses from receptors is preferentially 
metabolized by O-methylation (Hertting and Axelrod, 1961).
It is uncertain whether in man urinary normetadrenaline 
provides a better index of sympathetic activity than 
urinary noradrenaline (De Quattro and Sjoerdsma, 1968).
Isotopic Studies
Techniques have been devised for measuring the 
turnover rate of isotopically-labelled noradrenaline, and 
from comparison of the half-times, the relative activity 
of the sympathetic nervous system has been inferred.
Studies in which labelled noradrenaline is administered 
(Gitlow et al., 1964) have been difficult to interpret 
because these have not used "tracer” doses, and provide 
information only about noradrenaline clearance from 
plasma. If labelled noradrenaline precursors are 
administered, turnover rates of noradrenaline will
provide a measure of noradrenaline synthesis and 
metabolism, to the extent that the precursors mix 
homogeneously with the various neuronal noradrenaline pools 
(De Quattro and Sjoerdsma, 1968). A further problem in 
interpretation is that turnover rates will be influenced 
by intra-neuronal deamination, in addition to the rate of 
noradrenaline release and O-methylation.
Dopamine-3-hydroxylase
Noradrenaline and the enzyme dopamine-3-hydroxylase 
(DBH) are discharged in proportional amounts, by a process
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of exocytosis, on stimulation of adrenergic nerves 
(Axelrod, 1972). A sensitive assay for DBH has been 
developed (Molinoff et at, , 1971) and it is now possible to 
measure DBH activity in the plasma of man (Weinshilboum and 
Axelrod, 1971). The serum DBH arises from sympathetic 
nerve terminals and not from the adrenal medulla (Axelrod, 
1972). As DBH, unlike noradrenaline, is not subjected to 
reuptake after release, serum DBH levels hold promise of 
being a sensitive biochemical index of sympathetic nervous 
activity.
Studies of sympathetic nervous system activity and 
responsiveness in man have been plagued by the lack of 
a totally reliable, quantifiable chemical marker of post- 
synaptic sympathetic nerve fibre discharge. It is 
doubtful that the excretion of a single substance, be it 
noradrenaline, normetadrenaline, or VMA, provides a strictly 
quantitative chemical index of sympathetic activity. But 
for reasons presented, it would seem that the change in 
noradrenaline level with adrenergic stimulation provides 
at least a semi-quantitative index of change in sympathetic 
nervous activity. At the time of commencement of this 
work, existing plasma catecholamine assays were of doubtful 
reproducibility, and the decision was made to measure 
urinary free adrenaline and noradrenaline levels, by 
Crout's modification (Crout, 1961) of the trihydroxyindole 
method (Lund, 1949). From evidence presented here, and 
in Chapter 7, there is reason to believe that urinary 
catecholamine levels, adjusted for within-group differences 
in GFR, closely reflect plasma catecholamine levels. The 
recently introduced fluorimetric (Valori et al. , 1970) and
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double-isotope derivative (Engelman and Portnoy, 1970) 
assays for plasma catecholamines have the advantage of 
allowing the time course of an adrenergic response to be 
studied more closely. The serum dopamine-ß-hydroxylase 
assay (Molinoff et al. , 1971) holds promise of providing 
at last a method for accurate biochemical quantitation of 
sympathetic nervous system responses.
ASSAY OF URINARY FREE CATECHOLAMINES
Urinary free adrenaline and noradrenaline were estimated 
using Crout's modification (Crout, 1961) of the 
trihydroxyindole method (Lund, 1949), with differential 
fluorimetry using 2 sets of filters (von Euler and Lishajko, 
1959) . The trihydroxyindole assay is a 3-stage procedure:
1. The catecholamines are isolated from urine
and concentrated into a relatively pure extract 
by adsorption on alumina.
2. Noradrenaline and adrenaline are oxidized to 
aminochromes, then converted to fluorescent 
indole derivatives in alkaline solution.
3. The amines are measured fluorimetrically.
In the method of Crout, the catecholamines are
isolated from urine by a batch extraction with alumina, and 
eluted from the alumina with 0.20 N acetic acid. The 
oxidant used was 0.25% potassium ferricyanide (von Euler 
and Lishajko, 1959), not the 0.1 N iodine solution used by 
Crout. Interference from dopamine is less when ferri­
cyanide is used (von Euler and Floding, 1956). The problem 
of quenching was overcome by the use of EDTA, which prevents 
the formation of a gelatinous calcium magnesium phosphate
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precipitate in the final reaction mixture, and by running 
an internal catecholamine standard through the entire 
procedure.
Adrenaline and noradrenaline were assayed separately 
by differential fluorimetry using 2 pairs of settings for 
excitant and emergent wavelength (von Euler and Lishajko, 
1959). A Turner III fluorimeter and the following 
2 filter systems were used:
Setting a
Excitant: Wratten Filter (110-812), approx. 405 my. 
Emergent: Wratten Filter (65A), approx. 495 my.
This setting reads fluorescence for adrenaline: 
noradrenaline - 1:1.
Setting b
Excitant: Wratten Filter (2A+47B), approx. 436 my.
Emergent: Wratten Filter (2A-15), approx. 520 my.
Setting b reads adrenaline:noradrenaline - 3:1.
The adrenaline and noradrenaline content of the sample was 
derived from the simultaneous equations:
Ab A,
Noradrenaline = y = m(-r— )-n/N (— ■) -N,2 A ' a A ba a
Adrenaline = x = n-yN^/A^
m = Sample fluorescence-Blank fluorescence on filter 
setting a.
n = Sample fluorescence-Blank fluorescence on filter 
setting b.
A , A, = Fluorescence of adrenaline external standard a b
on settings a and b.
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N&, N^ = Fluorescence of noradrenaline external 
standard on settings a and b.
Recovery of added noradrenaline was 76 ± 6% (mean ± standard
deviation of difference in assayed duplicate pairs), and for 
added adrenaline was 75 ± 10%. Urinary catecholamine 
estimates were adjusted for recovery, based on the recovery 
of the internal standards in the day's assay.
ASSAY OF PLASMA RENIN ACTIVITY
Plasma renin activity was estimated by the bioassay 
method of Skinner (1967), using the anaesthetized ganglion- 
blocked rat. Recovery of angiotensin II added prior to 
preparation of the plasma was 82 ± 7% (mean ± standard 
deviation). The assay recorded zero plasma renin activity, 
at 60 hours incubation, in blood from a nephrectomized 
patient. The difference between 24 duplicate measurements 
of PRA was 6 ± 9% (mean ± standard deviation). The assay 
was performed in duplicate, on 2 different rats, and was 
repeated if duplicates differed by more than 24% (mean 
difference + 2.S.D.).
ENDOGENOUS CREATININE CLEARANCE
Urinary creatinine was determined by a modification 
of the alkaline picrate method (Edwards and Whyte, 1958).
Each estimation was performed in duplicate. Coefficient 
of variation for the assay, standard deviation x 100/mean, 
was 3%. Serum creatinine was measured by an SMA 
autoanalyzer.
There is considerable disagreement over the relationship 
of endogenous creatinine clearance to inulin clearance in 
health and in renal disease (Healy, 1968). Disparity is
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thought to arise from renal tubular secretion of creatinine 
(Shannon, 1S35), and from the presence of non-creatinine 
chromogen in plasma. Creatinine clearances based on plasma 
creatinine measurement using an autoanalyzer tend to give an 
underestimate of GFR when GFR is in the normal range, and 
to overestimate GFR when it is reduced. In a study by 
Healy (1968), in which inulin clearance and autoanalyzer 
endogenous creatinine clearance were simultaneously 
determined in 30 subjects, there was a correlation 
coefficient of 0.86 between results from the 2 methods.
In the 10 subjects with GFR greater than 90 mls/min, the 
ratio of autoanalyzer creatinine clearance to inulin 
clearance was 0.91.
In the studies to be described in subsequent Chapters, 
the estimation of GFR has been based on autoanalyzer 
creatinine clearances. In most cases, an estimate only of 
change in GFR was required, not of the absolute value.
In Chapter 7, where urinary catecholamine excretion is 
adjusted for within-group differences in GFR (estimated 
from autoanalyzer creatinine clearance), although absolute 
values are subject to a systematic error of approximately 
10%, the comparison of catecholamine levels in the 
different patient groups studied remains valid.
PSYCHOLOGICAL TESTING
The psychometric testing of hypertensive subjects 
employed questionnaire techniques. Questionnaires used 
were the I.P.A.T. Anxiety Scale Questionnaire (Cattell and 
Scheier, 1963) , and the Eysenck Personality Inventory,
Form A (Eysenck and Eysenck, 1964) which measures
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2 dimensions of personality, neuroticism-stability, and 
extraversion-introversion. The I.P.A.T. Anxiety Scale 
gives a measure of free-floating, manifest anxiety, which 
is increased in situationally determined anxiety reactions, 
or in chronic anxiety neurosis relatively independent of 
the immediate situation (Cattell and Scheier, 1963). 
Neuroticism, as measured by the Eysenck Personality 
Inventory, describes quantitatively the spectrum of 
personality ranging from stable individuals (low neuroticism 
score) through to unstable "neurotic" individuals (high 
neuroticism score).
For comparative purposes, a general medical group of 
40 patients, drawn from a medical ward and its associated 
outpatient department, and constituting a consecutive 
series of all new referrals in the age range 20-60 years, 
was studied. None of these patients was acutely ill at 




Patients with essential hypertension were drawn from 
more than 100 patients referred, during a 3-year period, 
for investigation of an elevated blood pressure. Secondary 
hypertension was reasonably excluded by routine screening 
procedures including urine microscopy and culture, serum 
sodium and potassium levels, endogenous creatinine clearance, 
urinary catecholamine excretion, and in most cases 
intravenous pyelography (no intravenous pyelogram in 
7 patients with borderline hypertension). None of the
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female patients was taking oral contraceptive drugs.
Most patients studied had never received treatment for the 
hypertension. A minority had received some treatment in 
the past, though not in the preceding 12 months.
Subjects with Normal Blood Pressure
The normotensive subjects consisted of student 
volunteers, and ambulant general medical patients drawn 
from a medical ward and its associated outpatient 
department. None of the patients was acutely ill, and 
most had been referred for diagnostic procedures.
The experimental procedures were explained fully to 
the subjects, and signed consent was obtained from all 
normal volunteers.
MISCELLANEOUS
(a) Urinary sodium and potassium were estimated with an 
EEL flame photometer.
(b) Plasma volume was measured using Evans Blue (Lawson, 
1962). Blood volume was calculated from estimates
of plasma volume and mean haematocrit (Chaplin et al. , 
1953).
(c) Blood pressure was measured with a sphygmomanometer, 
bag dimensions 30 x 12.5 cm, with the cuff at heart 
level.
(d) The "Severity Index" of the hypertensive disease was 
calculated using the point-score system of 
Corcoran et al. (1954).
(e) Excess body weight was expressed as a ponderal index 
(Grace and Goldrick, 1969).
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URINARY NORADRENALINE EXCRETION pg/hour
Figure 2-1. The relationship between creatinine 
clearance and urinary noradrenaline 
excretion in subjects with a normal 
blood pressure; r = +0.67, p < 0.001.
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CHAPTER 3
SYMPATHETIC NERVOUS SYSTEM RESPONSIVENESS TO HEAD-UP 
TILT IN ESSENTIAL HYPERTENSION
SUMMARY
The effect of 25° head-up tilt on blood pressure, 
urinary catecholamines, and creatinine clearance has been 
studied in untreated essential hypertensive patients and 
normotensive subjects.
The mean rise in diastolic pressure for all hyperten­
sives was 4.9 mmHg which did not differ significantly from the 
mean rise of 5.4 mmHg in the normal subjects. Ten of 41 
hypertensives had a diastolic pressure response greater than 
the response in any of 11 normal subjects, with a rise of 
greater than 10 mmHg.
The increase in urinary noradrenaline excretion with 
tilt was greater in these orthostatic hypertensives (1.74 
pg/hr) than in either the remaining hypertensives (0.34 
pg/hr) or the normotensive subjects (0.56 pg/hr). Overall 
there was a significant correlation between changes in 
diastolic blood pressure and urinary noradrenaline.
Creatinine clearance was reduced by tilting. The mean 
reduction was similar for normally reacting hypertensive and 
normotensive subjects (6% and 7.2% respectively). The 10 
orthostatic hypertensives, however, had a greater reduction 
in creatinine clearance (23.4%), and in the hypertensive 
group as a whole, change in diastolic blood pressure and 
creatinine clearance were negatively correlated.
The tilt hyperresponders tended to be young, not obese, 




In spite of the efficacy of adrenergic blocking drugs 
in lowering blood pressure in essential hypertension, it is 
generally thought that the unstimulated activity of the 
sympathetic nervous system and adrenal medulla is normal in 
this disorder (Peart, 1966). This apparent paradox has led 
to studies on responsiveness to stimuli that activate the 
sympatho-adrenomedullary system. Such stimuli include 
change in posture, which activates the sympathetic nervous 
system primarily, stimulating noradrenaline secretion 
(Sundin, 1956) and initiating neurovascular reflexes that 
affect blood pressure and modify renal function (Lee et al., 
1966). In one such study (Fröhlich et at., 1967), 
a proportion of hypertensive subjects responded abnormally 
to the stimulus of head-up tilt, with enhanced increases in 
blood pressure and total peripheral vascular resistance.
We have investigated the question of sympathetic 
responsiveness further, by measuring responses in blood 
pressure, urinary noradrenaline and glomerular filtration 
rate to head-up tilting in a group of normotensive and 
untreated essential hypertensive subjects.
METHODS
Forty-one untreated white hypertensive patients (30 
sustained essential hypertension, 11 borderline hypertension) 
and 11 white normotensive subjects were studied. Of the 
hypertensives, 32 had received no previous treatment for the 
hypertension, while 9 had received treatment for the 
hypertension in the past, but not in the preceding 12 months. 
The absence of recent treatment was related to the fact that 
all were either newly diagnosed hypertensives, borderline
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hypertensives, or previously diagnosed defaulters who had 
recently renewed contact with doctors, and were now referred 
for diagnostic procedures. The blood pressure elevation 
was designated sustained hypertension or borderline 
hypertension on the basis of average casual, or "usual", 
blood pressure (Julius and Schork, 1971). The average 
blood pressure during the first 2 days of hospital admission, 
or over several outpatient attendances, was in excess of 
155/95 mmHg in each of the patients with sustained 
hypertension. In patients with borderline hypertension, 
the average pressure under these conditions in each case 
fell within the range 145/90 - 155/95 mmHg, although 
occasional values were sometimes above 155/95 mmHg and 
sometimes below 145/90. The figures of 155/95 and 145/90 
are based on the distribution of blood pressure in 
population studies, such as reviewed by Julius and Schork 
(1971). Subjects with isolated systolic hypertension and 
normal diastolic pressures were not included in the study. 
Secondary hypertension was reasonably excluded by routine 
screening procedures including urine microscopy and culture, 
serum and 24-hour urinary sodium and potassium levels, 
endogenous creatinine clearance, urinary catecholamine 
excretion, and in most cases intravenous pyelography (no 
intravenous pyelogram in 4 patients with borderline 
hypertension). None of the female hypertensives was 
taking oral contraceptive drugs. The severity of the 
hypertensive disease was graded according to the scale of 
Corcoran et at, (1954), and the patients' adiposity 
estimated from a ponderal index (Grace and Goldrick, 1969).
In 26 of the 41 hypertensive patients it was felt that
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estimation of the duration of hypertension was possible, 
with adequate documentation from previous frequent medical 
examination related primarily to employment. Duration 
was dated from the time that elevated pressure was first 
noted, whether borderline or sustained elevation. The 11 
normotensive subjects comprised 7 student volunteers and 
4 ambulant hospital inpatients. None had cardiovascular 
disease, or a family history of hypertension.
The investigation was performed on the hypertensives 
as outpatients (23 subjects) or during the first two days 
of hospital admission (18 subjects) to minimize any effects 
of confinement and prolonged recumbency (Dietrick et al., 
1948). Changes with tilting in blood pressure, urinary 
noradrenaline, and glomerular filtration rate were measured. 
After an overnight fast, subjects were rested supine in 
a single bed ward for 90 minutes prior to the commencement 
of the study. Then followed a 90-minute period of 
recumbent rest, and after venepuncture, a further 90 minutes 
consisting of 15 minutes for stabilization of blood pressure 
and pulse rate after venepuncture, and terminating in 75 
minutes of head-up tilt. Subjects voided at the end of 
both these periods, and the urine was acidified and frozen 
for storage prior to estimation of catecholamines and 
creatinine. Drinking water was given throughout to ensure 
an adequate urine flow. Blood pressure was measured with 
a sphygmomanometer at 10-minute intervals during the period 
of recumbent rest. Disappearance of sound was taken as 
the diastolic end-point. Blood was drawn at the end of 
the period of recumbency for estimation of serum creatinine. 
After collection of the first urine sample and venepuncture,
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blood pressure and pulse rate were repeatedly measured until 
they had returned to pre-venepuncture levels, which 
invariably occurred within 15 minutes. A stable pre-tilt 
baseline having been obtained, subjects were then tilted 
head-up on a tilt-table with a boot-board at 25° tilt for 
75 minutes. With the sphygmomanometer cuff at heart-level, 
blood pressure was measured at 2-minute intervals for the 
first 20 minutes of tilt and at 10-minute intervals there­
after. Blood pressure and pulse rate changed on tilting 
to reach a stable peak response within 5 minutes or so, then 
remained almost constant for 20-30 minutes, after which 
there was a gradual return towards pre-tilt values. The 
blood pressure and pulse rate responses were taken as the 
means of the 3 maximum deviations from the immediate 
pre-tilt levels during the first 20 minutes of tilt. This 
in effect recorded the plateau of blood pressure and pulse 
rate response to tilt, eliminating the periods of early 
circulatory adjustment, and slow return towards baseline if 
this occurred sooner than 20 minutes after commencing 
tilt.
Urinary free noradrenaline and adrenaline were 
determined in duplicate with a Turner III fluorimeter by 
differential fluorimetry with 2 sets of filters (von Euler 
and Lishajko, 1959) but otherwise using the method of Crout 
(1961). Internal standards were carried through the 
entire procedure.
Urinary creatinine was determined by the alkaline 
picrate method (Edwards and Whyte, 1958) and serum 
creatinine by autoanalyzer.
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In 18 subjects, plasma volume was measured on the 
morning of the test using Evans Blue. From this, and the 
estimated mean haematocrit (Chaplin et al., 1953), blood 
volume was calculated.
Questionnaire-based psychometric testing was performed 
in patients with elevated blood pressure. Psychometric 
testing was performed within 2 weeks of the tilt studies, 
but not on the day of the tilt test. Questionnaires used 
were the I.P.A.T. Anxiety Scale Questionnaire (Cattell and 
Scheier, 1963) which is primarily a measure of free-floating 
or manifest anxiety, and the Eysenck Personality Inventory 
(Eysenck and Eysenck, 1964) which measures 2 dimensions of 
personality, neuroticism-stability and extraversion- 
introversion .
RESULTS
The relevant details about the subjects, and the 
responses to tilt, are listed in Tables 3-1, 3-2, and 3-3.
For the purposes of this study, patients with 
borderline and sustained hypertension have been incorporated 
into a single group. They have been treated as a continuum 
in this way to facilitate evaluation of the responses in 
relation to the severity index of the hypertensive process. 
This is not to imply homogeneity of the group, or 
a necessary progression with time from borderline to 
sustained hypertension. Although some indices of 
sympathetic responsiveness correlated overall with severity 
of the hypertension, in no case did the response in 
borderline hypertensives as a group differ significantly 
from that in sustained hypertensive or normotensive subjects.
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Change in Systolic Blood Pressure
The change in systolic blood pressure in the 
hypertensives was -4.5 ± 7.8 mmHg (mean ± standard deviation) 
and in the normotensives -1.1 ± 4.0 mmHg. The difference 
in the means was not significant, but the hypertensives 
demonstrated a significantly greater scatter of systolic 
pressure responses (variance ratio = 3.80, p < 0.01). The 
normal subjects maintained their systolic blood pressure in 
the face of orthostatic stress better than many of the 
hypertensives, 13 of whom, with falls of 10 mmHg or more, 
had a fall in systolic blood pressure more than 2 standard 
deviations greater than the mean fall in the normal subjects. 
These hypertensives tended to have more severe disease and 
overall there was a significant negative correlation between 
changes in systolic blood pressure and severity index 
(r = -0.37, p < 0.02).
Change in Diastolic Blood Pressure
Change in diastolic blood pressure in the hypertensives 
was +4.9 ± 6.6 mmHg and in the normotensives, +5.3 ± 3.3 
mmHg (difference in means not significant; variance ratio = 
3.76, p < 0.01). Ten of 41 hypertensives, with diastolic 
blood pressure rises of 11 mmHg or more, reacted as 
"orthostatic hypertensives" with a rise in diastolic pressure 
greater than the rise in any of 11 normal subjects. Of the 
10 orthostatic hypertensives, 4 had borderline hypertension,
4 had mild sustained hypertension and 2 (patients 7 and 9) 
had moderately severe sustained hypertension. For the 
hypertensive group as a whole there was only a low order of 
negative correlation between changes in diastolic blood 
pressure and severity index (r = -0.27, 0.05 < p < 0.1).
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Change in Urinary Noradrenaline
There were substantial changes in creatinine clearance 
with tilting, and urinary noradrenaline excretion was 
corrected for these changes*. There was a significant rise 
in uncorrected mean urinary noradrenaline excretion,
+0.41 yg/hr for hypertensives (p < 0.01, paired t-test) and 
+0.42 yg/hr for normotensives (p < 0.05). The changes in 
adjusted urinary noradrenaline excretion, +0.68 ± 0.96 yg/hr 
for hypertensives and +0.56 ± 0.51 yg/hr for normotensives, 
did not differ significantly, but hypertensives demonstrated 
a wider range of noradrenaline responses (variance ratio 
3.54, p < 0.02). In 8 of 41 hypertensives, who showed 
increases greater than 1.6 yg/hr the noradrenaline response 
was more than 2 standard deviations beyond the mean 
increment for normal subjects. Of these 8 noradrenaline 
hyperresponders, 6 behaved also as orthostatic hypertensives. 
For the hypertensive group as a whole there was 
a significant correlation between changes in diastolic blood 
pressure and urinary noradrenaline (r = 0.53, p < 0.001)
(Fig. 3-1).
The noradrenaline response tended to be smaller in 
patients with longstanding hypertension (duration of 
hypertension vs . noradrenaline response, r = -0.38,
0.05 < p < 0.1: (Fig. 3-2)).
* Change in noradrenaline = measured urinary noradrenaline 
(tilted) x creatinine clearance recumbent/creatinine 
clearance tilted - measured urinary noradrenaline 
(recumbent).
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There was also a trend for severity index and 
noradrenaline responsiveness to be negatively correlated, 
although this did not reach statistical significance (Fig. 
3-3) .
There was no correlation between the level of urinary 
noradrenaline during recumbency and the increase with 
tilting.
Blood volume was measured in 10 male hypertensives 
and 8 male normotensives. Noradrenaline response to tilt 
was unrelated to blood volume in either group.
Change in Creatinine Clearance
A fall in mean creatinine clearance occurred with tilt, 
and this was of similar magnitude in hypertensives and 
normotensives with reductions of 10.2 ± 17.2% and 
7.2 ± 13.7% respectively. The large standard deviations 
partly reflect technical factors as endogenous creatinine 
clearances based on voided specimens give less than ideal 
reproducibility. Coefficient of variation* for endogenous 
creatinine clearance performed at the same time on 
successive days in 20 subjects was 11.9% and coefficient 
of variation for successive collection periods on the same 
day has been reported as 8.1% (Healy, 1968). But the 
scatter of responses observed probably also reflects 
physiological differences. The mean fall in the 
orthostatic hypertensives was 21.3% compared with a fall 
in the remaining hypertensives of 6.0% (t = 2.92 p < 0.01),
/Error variance'
Combined mean* Coefficient of variation = 100 x
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and for the hypertensive group as a whole, there was 
a significant correlation between rise in diastolic blood 
pressure and fall in creatinine clearance; r = 0.40, 
p < 0.01 (Fig. 3-4).
Psychometrics
Anxiety scores in borderline hypertensives, 23.2 ± 10.5, 
and sustained hypertensives, 30.7 ± 13.4, did not differ 
significantly. The neuroticism scores in borderline and 
sustained hypertension, 7.9 ± 5.5 and 10.9 ± 5.8 respectively, 
also were not significantly different. Overall, there was 
no correlation between anxiety and neuroticism scores, and 
the sympathetic responses to tilting shown by the 
hypertensives.
DISCUSSION
An accentuated blood pressure rise with tilting occurs 
in approximately one third of all patients with essential 
hypertension (Fröhlich et al., 1967). Results have been 
presented here consistent with the concept that enhanced 
sympathetic nervous system responsiveness underlies an 
orthostatic hypertensive response. This enhanced 
responsiveness was manifested as greater change in diastolic 
blood pressure, urinary noradrenaline, and glomerular 
filtration rate in the hyperresponders to tilt.
The basis of such an enhanced responsiveness remains 
uncertain, but it seems unlikely that the tilt hyperresponders 
were more anxious than the remaining hypertensives, and that 
an accentuated response to tilting only reflected a greater 
degree of apprehension about the procedure. Questionnaire 
scores of anxiety and neuroticism in the tilt hyperresponders
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did not differ significantly from the scores in the 
remaining hypertensives. Furthermore, adrenaline excretion, 
an index of anxiety (von Euler, 19 64) , was not raised in the 
orthostatic hyperresponders.
Some of the clinical characteristics of the tilt 
hyperresponders, the 12 hypertensives with greater rises in 
diastolic blood pressure, urinary noradrenaline, or both, 
than seen in normotensives, warrant mention. As a group, 
the tilt hyperresponders tended to be young, not obese, 
with hypertension of recent onset. All 12 hyperresponders 
were less than 45 years while 10 of 29 normal responders 
were over 45 (p < 0.05*). Age appears to have little 
influence on noradrenaline, blood pressure or renal 
responses to orthostatic stress in normal subjects (Lee 
et at., 1966; Hickler et al. , 1959; Strandell, 1964). 
Duration of the hypertension was known in 8 of the 12 tilt 
hyperresponders, and was in no case more than 5 years. In
9 of 18 normally responding patients, hypertension had been 
present for more than 5 years (p < 0.05*) and in 7 for
10 years or more. Fourteen of 29 normally responding 
hypertensives were obese, having a ponderal index of 2.6
or more, equivalent to greater than 115% ideal body weight. 
None of the 12 hyperresponders were obese (p < 0.01*).
An enhanced sympathetic responsiveness to tilt may be 
a common accompaniment of early, mild essential hypertension, 
to be lost later if the hypertensive process becomes more 
severe. It is of interest in this regard that when the 
study was repeated after an interval of 1-2 years, in 
4 patients with mild sustained hypertension, and one with 
borderline hypertension, who initially showed an
* Chi-square test of significance
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accentuated response to tilting, the changes in diastolic 
blood pressure, urinary noradrenaline, and creatinine 
clearance observed on retesting were marginally lower than 
the earlier responses in each of these 5 patients. However 
the responses were not significantly less (paired t-test), 
and in 4 of the 5 still constituted a greater than normal 
response to tilt.
The evidence for increased sympathetic activity in 
essential hypertension has been reviewed by Nestel and 
Esler (1.970) . It seems probable that resting hypertensive 
subjects on the whole do not excrete increased amounts of 
catecholamines, although a proportion of hypertensives 
demonstrate elevated excretion of catecholamines and their 
metabolites. In the present study, 8 of 41 hypertensive 
patients had a resting urinary excretion of noradrenaline 
more than 2 standard deviations greater than the mean 
excretion rate in the normal subjects. These tended to be 
patients with higher blood pressures and more severe 
hypertensive disease. Among subjects with mild, untreated 
hypertension the output of catecholamines may be normal in 
the absence of stress, but may be above normal during stress. 
An increased response measured in terms of increased 
arterial pressure and urinary catecholamines, has also been 
observed in young, mild hypertensive patients when stressed 
with mental arithmetic (Nestel, 1969).
There are several studies in the literature reporting 
normal plasma and urinary noradrenaline responses to tilt 
in essential hypertension (Sundin, 1956; Hickler et al. , 
1959). These differ from the present study in several 
respects. The number of patients studied was generally
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small, and included mainly those with severe sustained 
hypertension. An enhanced noradrenaline response to change 
in posture has been described in subjects with "hyperkinetic 
circulation", in association with both normal and elevated 
blood pressure (Kuchel et al., 1970). It is of interest in 
this regard that 3 of the tilt hyperresponders had symptoms 
of recurrent palpitations and chest discomfort suggestive 
of hyperdynamic 3-adrenergic disease (Fröhlich et al., 1969).
Differences in blood pressure responses to tilt between 
normally reacting hypertensives and orthostatic hypertensives 
reflect a greater increase in total peripheral vascular 
resistance in the latter (Fröhlich et al. , 1967). In this 
study, orthostatic hypertensives had the largest increment 
in urinary noradrenaline, and for all hypertensives, 
a significant relationship was found between the increments 
in diastolic pressure and urinary noradrenaline. This 
suggests a possible quantitative relationship between 
increased sympathetic nerve discharge to arterioles and the 
rise in diastolic pressure. Although the rate of
noradrenaline excretion in the urine is a very indirect 
measure of sympathetic activity, several lines of evidence 
suggest that it may be a valid index. Patients with 
autonomic degeneration excrete reduced amounts of 
noradrenaline in the urine (Goodall et al. , 1968) . When 
a sympathetic nerve trunk is electrically stimulated the 
rate of noradrenaline release into venous blood is related 
to the frequency of sympathetic nervous discharge (Brown 
and Gillespie, 1957). Plasma and urinary noradrenaline 
concentrations rise in response to change in posture (Sundin, 
1956; Hickler et al., 1959) but the relative contribution
51.
by sympathetic nerves in different sites to the total 
noradrenaline plasma pool is unknown. Since 
adrenalectomized patients have been shown to have a normal 
noradrenaline response to tilt (von Euler & Franksson, 1957) 
it is presumed that the sympathetic nerves to arterioles 
are the major source of the noradrenaline increment. But 
other sites, such as the heart (Braunwald et al. , 1964) may 
also contribute. Furthermore, an increase in the amount 
of noradrenaline overflowing into plasma may reflect 
diminished reuptake by the nerve ending, and need not 
necessarily indicate an increased frequency of sympathetic 
nerve discharge. Finally, it has been assumed that plasma 
noradrenaline is passively handled by the kidney, so that 
urinary excretion, corrected for differences in glomerular 
filtration rate, reflects the plasma concentration.
Although this assumption is commonly made, there is no 
evidence available on this point in man, and some evidence 
to the contrary in dogs (Overy et al. , 1967) .
Renal physiology is affected by posture. Tilting 
reduces renal blood flow and glomerular filtration rate 
and elevates renal vascular resistance (Lee et al. , 1966). 
It has been suggested that the fall in GFR is produced by 
vasoconstriction of afferent arterioles (Smith, 1939-40).
We have found that the orthostatic hypertensives had the 
largest falls in GFR, and for the hypertensive group as 
a whole, change in diastolic pressure and GFR were 
negatively correlated. As an increase in total peripheral 
vascular resistance underlies the increase in diastolic 
pressure with tilting (Fröhlich et al. , 1967), increases in 
renal afferent arteriolar resistance and total peripheral 
resistance would seem to be closely related.
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From which level of the barostat reflex arc the broad 
spectrum of responsiveness in essential hypertension derives 
is not clear. The response to tilt may be influenced by 
blood volume (Jeffrey et al, , 1970; Ramirez and Abelman, 
1968). Contraction of the plasma volume has been described 
in essential hypertension, but this is a prominent finding 
only in patients with more severe disease (Tarazi et al. , 
1968) . In the present study, the largest sympathetic 
responses tended to occur in patients with borderline and 
mild sustained hypertension, and in fact noradrenaline 
response to tilt and blood volume appeared to be unrelated. 
There is some evidence that the sensitivity of the 
baroreceptors is reduced in severe hypertension, but is 
virtually normal in mild hypertension (Bristow et al. , 1969). 
This observation may be relevant to the diminished tolerance 
to orthostatic stress noted in some patients with more 
severe hypertension, but leaves the phenomenon of tilt 
hyperresponsiveness unexplained. A primary defect on the 
efferent limb of the barostat reflex, at the level of 
central integration of sympathetic function, or at the nerve 
ending, such as has been suggested in hyperkinetic 
circulation (Kuchel et al. , 1970) remains an untested 
speculation.
The pathogenic significance, if any, of the broad 
spectrum of sympathetic nervous system responsiveness in 
essential hypertension is not clear, but there may be 
relevance to the phenomenon of 'renin unresponsive 
essential hypertension". Approximately 20% of essential 
hypertensives have low plasma renin activity during 
recumbency, and react to stimuli such as upright posture
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with smaller rises in plasma renin than normal subjects 
(Channick et al. , 1969). There is evidence that the 
sympathetic nervous system plays an important role in renin 
release (Gordon et al. , 1967). The relationship of renin 
responsiveness to sympathetic nervous responsiveness in 
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HYPERTENSIVE SUBJECTS - RESPONSE TO 25° HEAD-UP TILT
Change in Change in Change in Change in Change in Change in
Systolic Diastolic Pulse Urinary Urinary Creatinine
BP BP Rate Noradrenaline Adrenaline Clearance
(mmHg) (mmHg) (yg/hour) (yg/hour) (%)
1 +7 +18 +24 +2.04 +1.43 -23
2 0 +15 +18 +1.73 -0.09 -14
3 +3 +14 +6 + 3.79 +1.03 -57
4 +4 +14 +10 + 1.11 0 -12
5 + 2 +13 +12 +1.18 0 -6
6 0 +13 +16 +0.18 +0.78 -17
7 +3 +12 + 9 +1.70 -0.04 -2
8 +5 +11 + 8 +2.86 -0.21 -47
9 -12 +11 +18 +2.21 +0.53 -34
10 -9 +11 + 8 + 0.62 + 0.14 -22
11 +12 +10 0 + 1.70 -0.54 -34
12 + 3 + 8 +12 + 1.17 + 0.48 -22
13 -4 + 8 + 4 -0.28 -0.26 + 27
14 0 + 8 + 8 +1.14 + 0.11 -10
15 -12 + 8 +2 + 0.10 -0.06 -3
16 -10 + 7 +12 + 0.59 0 -13
17 -8 + 7 + 8 + 0.37 -0.17 + 2
18 0 + 7 + 4 + 0.35 -0.40 -19
19 0 +6 + 2 + 0.35 + 0.32 -29
20 +5 + 6 + 6 -0.62 -0.23 + 26
21 -8 + 5 + 12 + 0.98 + 0.32 -22
22 -25 + 5 + 8 + 0.06 + 0.12 -15
23 -5 + 4 +18 +1.06 + 0.35 + 2
24 -10 + 4 + 6 -0.07 + 0.38 + 4
25 0 + 3 +14 0 +0.29 -3
26 0 + 3 + 5 + 0.86 +0.05 -20
27 -11 + 2 + 12 -0.36 0 -2
28 -10 + 2 0 + 0.18 0 +1
29 -5 + 2 + 6 -0.04 + 1.23 -9
30 -7 + 2 + 4 -1.23 -1.20 + 20
31 -4 + 2 + 10 + 0.66 + 0.44 -16
32 -12 +2 +18 + 0.25 + 0.24 -14
33 -11 0 + 10 + 0.51 + 0.13 +4
34 -5 -3 0 + 1.06 -0.16 -12
35 -4 -3 + 6 -0.08 + 0.43 -11
36 0 -3 + 12 -0.06 +0.33 -14
37 -14 -4 + 14 + 1.64 + 0.73 -15
38 0 -5 + 6 + 0.45 + 0.80 -2
39 -18 -6 + 3 + 0.15 +0.03 -16
40 -17 -8 +18 -0.02 + 0.28 + 23
41 -16 -10 + 7 -0.31 + 0.69 + 7
Mean+
S.D.
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Change in Diastolic Blood Pressure mm Hg
•  hypertensives 
O normals
Figure 3-1. The relationship between responses in 
diastolic blood pressure and adjusted 
urinary noradrenaline excretion* to 25° 
head-up tilt. For hypertensive and 
normotensive subjects combined; 
r = +0.50, p < 0.001.
* Change in noradrenaline = measured urinary 
noradrenaline (tilted) x creatinine clearance 
(recumbent)/creatinine clearance (tilted) - 
measured urinary noradrenaline (recumbent).
1-0
-0-51_________________________ I0-4 5-8 9-12 13-16 17-20
(15) (4 ) (2 ) (2) (3)
Duration of Hypertension years
Figure 3-2. The relationship between
duration of hypertension and 
adjusted noradrenaline response 
to tilt. Means and standard 
errors are shown. Numbers of 
subjects in each interval are 
indicated in brackets 




















(n) (11) (17) (9) (4)
Figure 3-3. Change in adjusted urinary noradrenaline 
excretion with tilting in normal subjects 
(N), borderline hypertensives (B), and 
3 grades of sustained essential 
hypertension (I = mild hypertension, 
severity index <2.5; II = moderately 
severe hypertension, severity index 
2.5 - 5.0; III = severe hypertension, 
severity index > 5.0). Means and 
standard errors are shown. Numbers of 



















Change in Diastolic Blood Pressure mm Hg
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The relationship between changes in 
diastolic blood pressure and creatinine 
clearance with 25° head-up tilt. For 





RESPONSIVENESS OF THE SYMPATHETIC NERVOUS SYSTEM AND RENIN- 
ANGIOTENSIN SYSTEM TO ADRENERGIC STIMULI IN 
ESSENTIAL HYPERTENSION
SUMMARY
The change in plasma renin activity and urinary 
catecholamine excretion with head-up tilting, insulin 
hypoglycaemia, and "mental stress" has been studied in 
patients with essential hypertension and subjects with 
a normal blood pressure. There was a significant increment 
in urinary adrenaline excretion with hypoglycaemia and 
mental stress in both groups, but changes in PRA were 
minimal, there being a small but significant rise 
in PRA with hypoglycaemia only, in the hypertensives, and 
with neither stimulus in the normotensive subjects. PRA 
and urinary noradrenaline excretion rose significantly with 
tilting in the hypertensive and normotensive subjects. The 
PRA response was greatest in hypertensives with an enhanced 
sympathetic responsiveness to tilting. Conversely, in low- 
renin essential hypertensives, the noradrenaline response 
was reduced. Overall, among the hypertensive subjects, the 
PRA and noradrenaline responses to tilt showed a positive 
correlation (r = + 0.69, p < 0.01).
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INTRODUCTION
The control of renin secretion appears to be achieved 
through 3 independent mechanisms (Davis, 1971). The 
"macula densa theory" views the macula densa of the distal 
renal tubule as a sodium sensor, receptive to changes in 
sodium load delivered to the distal tubule (Vander and 
Carlson, 1969) . The "baroreceptor hypothesis" (Skinner 
et al. , 1964) holds the glomerular afferent arteriole to 
be an intrarenal baroreceptor, sensitive to changes in renal 
arterial pressure. The third factor directly influencing 
renin release is the activity of the renal sympathetic nerves 
(Vander, 1965) and perhaps the plasma concentration of 
catecholamines (Otsuka et al., 1970). The predominant 
mechanism mediating the renin response in a particular 
situation depends on the circumstances. With adrenergic 
stimuli, such as hypoglycaemia (Otsuka et al. , 1970) and 
change in posture (Oparil et al., 1970), the renal 
sympathetic nerves and circulating catecholamines seem to 
have the dominant role, as the renin response can be 
abolished by adrenergic receptor-blocking drugs (Assaykeen 
et al. , 1970 ; Winer et al. , 1969).
In recent years it has become clear that in 
approximately 20-30% of patients with essential hypertension, 
plasma renin activity is low at rest, and rises less than 
anticipated with stimuli such as sodium depletion and the
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upright posture (Crane et al., 1972). Current research is 
largely directed towards the possibility that in "low-renin 
essential hypertension" a sodium-retaining hormone, other 
than aldosterone, may be secreted in excess by the adrenal 
gland (Woods et al. , 1969). It is thought likely that the 
suppression of renin release reflects sodium retention.
The activity of the sympathetic nervous system in this 
disorder has been little studied. Crane et al. (1972) have 
reported low urinary catecholamine excretion in low-renin 
essential hypertension, but Jose et al. (1970) found PRA
and urinary catecholamine level to be unrelated.
A reduction in the reflex responsiveness of the sympathetic 
nervous system has been described in essential hypertension 
(Fröhlich et al. , 1967): approximately one third of
essential hypertensives responded to head'-up tilting with 
a reduced rise in total peripheral vascular resistance and 
postural hypotension. Whether reduced reflex sympathetic 
activity in hypertensives with such an "orthostatic 
hypotensive" response is related to the phenomenon of 
low-renin hypertension has not been investigated.
This possibility has been tested in the present study, 
in which urinary catecholamine excretion and plasma renin 
activity have been measured concurrently, at rest and with 
head-up tilting, insulin hypoglycaemia, and mental stress, 
in patients with essential hypertension and subjects with 
normal BP.
METHODS
Forty-one untreated hypertensive patients (31 sustained 
essential hypertension, 10 borderline hypertension) and
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20 normotensive subjects were studied. The sympathetic 
nervous system responsiveness to tilting in 33 of the 
hypertensives and 9 of the subjects with normal BP has been 
described previously in Chapter 3. Of the hypertensives,
34 had received no previous treatment for the hypertension, 
while 1 had received treatment in the past, though not in 
the preceding 12 months. The blood pressure elevation was 
designated sustained hypertension or borderline hypertension 
on the basis of average casual or "usual" BP (Chapter 3). 
Secondary hypertension was reasonably excluded by routine 
screening procedures including urine microscopy and culture, 
serum and 24-hour urinary sodium and potassium levels, 
endogenous creatinine clearance, urinary catecholamine 
excretion, and in most cases intravenous pyelography (no 
intravenous pyelogram in 5 patients with borderline 
hypertension). None of the female hypertensives was 
taking oral contraceptive drugs. The 20 normotensive 
subjects comprised 9 student volunteers and 11 ambulant 
general medical patients. None had cardiovascular or 
renal disease, or a family history of hypertension.
The investigations were performed on the hypertensives 
as outpatients (25 subjects), or during the first three days 
of hospital admission (16 subjects) to minimize any effects 
of confinement and prolonged recumbency (Dietrick et al., 
1948). Subjects were maintained on an unrestricted diet, 
and fasted overnight before each procedure.
EXPERIMENTAL PROCEDURES
Head-up tilting. The changes in blood pressure, 
urinary catecholamine excretion, creatinine clearance, plasma
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renin activity, and urinary sodium excretion with 25° head- 
up tilting were measured in the 41 patients with hypertension 
and 12 subjects with normal BP. The experimental procedure 
was as outlined in Chapter 3. In addition, peripheral 
venous blood was drawn at the end of the period of supine 
rest and after 90 minutes of tilt, for assay of plasma renin 
activity. Urine was also collected at both these times, 
and stored prior to the estimation of sodium concentration.
Insulin Hypoglycaemia. The change in blood pressure, 
urinary catecholamine excretion, plasma renin activity, plasma 
volume, and creatinine clearance with insulin-induced 
hypoglycaemia was studied in 6 hypertensive patients, and 
6 subjects with normal BP. The experimental procedure was 
as follows: A 21 G scalp-vein needle was inserted in an arm
vein 60 minutes prior to commencing the study, and the 
catheter kept open with a slow infusion of 0.9% saline. 
Subjects were then rested flat for one hour, at the end of 
which they emptied their bladder. The experiment comprised 
2 test periods; 90 minutes of supine rest, and then 
following the injection of soluble insulin, 0.03 u/Kg, 
a further 120 minutes. Urine was collected at the 
end of both these periods, acidified, and frozen for storage 
prior to the estimation of urinary free catecholamines and 
creatinine. Blood pressure was measured with 
a sphygmomanometer at 10-minute intervals during the pre­
insulin period, and at 5-minute intervals thereafter.
Venous blood was withdrawn via the catheter, for estimation 
of blood glucose, immediately prior to the administration 
of insulin, and at 15, 30, 45, 60, and 120 minutes
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post-insulin. Blood sampling for the estimation of serum 
creatinine and PRA was performed immediately before the 
administration of insulin, and again 45 minutes post-insulin. 
Plasma volume was measured twice, with Evans Blue, during 
the pre-insulin period, and at 60 minutes post-insulin.
Mental Stress. The effect of an anxiety-provoking 
situation on blood pressure, urinary catecholamine excretion, 
and PRA was studied in 10 hypertensive patients and 
6 subjects with normal BP. The procedure used was that of 
Nestel (1969), in which solving visual puzzles against the 
clock constitutes the stimulus. The experiment comprised 
2 test periods; 90 minutes of supine rest, followed by 
a 2-hour period which commenced with 45 minutes of "mental 
stress". Urine was collected for assay of catecholamines 
and creatinine at the end of both periods. Blood pressure 
was measured with a sphygmomanometer during the pre-stress 
period, and throughout the 45 minutes of mental stress, and 
the mean BP response calculated. Venous blood was withdrawn 
twice for the estimation of plasma renin activity and serum 
creatinine, at the end of the pre-stress period, and after 
45 minutes of problem-solving.
Urinary free noradrenaline and adrenaline were assayed 
in duplicate by a modification of the trihydroxyindole 
method (Crout, 1961) with differential fluorimetry using 
2 sets of filters (von Euler and Lishajko, 1959). Urinary 
creatinine was measured by a modification of the alkaline 
picrate method (Edwards and Whyte, 1958) , serum creatinine 
was measured by autoanalyzer. From the serum creatinine 
concentration and urinary creatinine excretion, endogenous
60.
creatinine clearance was calculated. Urinary noradrenaline 
and adrenaline excretion was adjusted for within-group 
differences in GFR, and for incomplete emptying of the 
bladder, as follows:
Adjusted catecholamine excretion (yg catecholamine/ 
litre of plasma cleared of creatinine) = catecholamine 
excretion (yg/min)/GFR (litre/min). The validity of this 
adjustment is discussed in Chapter 2 and 7.
Plasma renin activity was measured using the bioassay 
method of Skinner (1967). Urinary sodium concentration was 
estimated by flame photometry. Blood glucose concentration 
was estimated using the glucose oxidase method (Huggett and 
Nixon, 1957).
RESULTS
Resting Values of Noradrenaline, Adrenaline, PRA.
Plasma renin activity at rest was similar in the 41 
hypertensive patients and the 20 subjects with normal BP, 
1.23 ± 0.76 ng/ml/hr (mean ± standard deviation) in the 
hypertensives compared with 1.18 ± 0.34 ng/ml/hr in the 
normotensives. Urinary adrenaline excretion was also 
similar in the hypertensives (0.08 ± 0.06 yg/1) and the 
subjects with normal BP (0.07 ± 0.05 yg/1). Mean urinary 
noradrenaline level was significantly higher in the 
hypertensives; 0.25 ± 0.12 yg/1 compared with 0.18 ± 0.07 
yg/1 (p < 0.05). Plasma renin activity was not related to 
either urinary adrenaline or urinary noradrenaline 
excretion in either group.
Response to Head-up Tilting. The mean changes in 
diastolic blood pressure, urinary noradrenaline, PRA, and 
GFR on tilting were similar in hypertensive and normotensive
61.
subjects. There was a rise in diastolic BP of 4.9 ± 6.8 
mmHg in hypertensives (p < 0.01, paired t-test) and 
5.1 ± 3.4 mmHg in normotensive subjects (p < 0.05) on 
tilting. Change in noradrenaline level in hypertensives 
was + 0.08 ± 0.11 pg/1 (p < 0.01), and in normotensives 
+ 0.05 ± 0.05 Mg/1 (p < 0.05). The PRA response was 
+ 0.27 ± 0.31 ng/ml/hr in patients with hypertension 
(p < 0.01), and + 0.34 ± 0.24 ng/ml/hr in subjects with 
normal BP (p < 0.01). Glomerular filtration rate fell with 
tilting in both groups, by 10.0 ± 17.4% in hypertensives 
(p < 0.01) and by 7.5 ± 13.8% in the normotensive subjects 
(p < 0.05). The mean responses in the 2 groups were not 
significantly different.
The noradrenaline and renin response in the hypertensive 
subjects was positively correlated; r = + 0.69, p < 0.01, 
Fig. 4-1. Among the 12 subjects with normal BP there was 
also a trend for change in PRA. and noradrenaline to correlate 
directly, but the correlation was of low order and not 
significant (r = + 0.34, Fig. 4-1). The change in PRA was 
not related to changes in GFR or urinary sodium excretion 
in either group.
Twelve of 41 patients with essential hypertension who 
showed a rise in diastolic BP of 11 mmHg or more, or an 
increase in urinary noradrenaline greater than 0.15 yg/1 in 
response to tilting, were categorized as "sympathetic 
hyperresponders" on the basis of rises in blood pressure or 
noradrenaline above the range of responses observed in 
the normal subjects (Chapter 3). In 7 of these 12, both 
blood pressure and noradrenaline response were above the 
normal range. Plasma renin activity at rest was higher
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in this group than in the normotensive subjects; 1.80 ± 0.90 
ng/ml/hr compared with 1.14 ± 0.38 ng/ml/hr (p < 0.05, Fig. 4- 
2). The increase in PRA with tilting was also greater,
0.56 ± 0.21 ng/ml/hr compared with 0.34 ± 0.24 (p < 0.05).
PRA with tilting was 1.48 ± 0.41 ng/ml/hr in the 
subjects with normal BP. Six of the essential hypertensives, 
with a PRA of less than 0.66 ng/ml/hr after 90 minutes of 
head-up tilt, had a renin level more than 2 standard 
deviations below the mean PRA during tilting in the 
normotensive subjects, and were categorized as "low-renin 
essential hypertensives". This group tended to have 
diminished sympathetic responsiveness to tilting, with 
smaller rises in noradrenaline level and blood pressure, and 
a smaller fall in GFR than occurred in the subjects with 
normal BP, or the hypertensive group as a whole (Fig. 4-2).
It was anticipated that the "sympathetic hyperresponders", 
with larger rises in PRA and greater falls in GFR, might 
display a greater degree of sodium retention with tilting 
than the other hypertensives, but this was not confirmed 
(Fig. 4-3).
Response to Hypoglycaemia. Although the fasting blood 
glucose level prior to insulin was higher in the 
hypertensive subjects (p < 0.05, Fig. 4-4), the mean maximal 
falls with insulin, 49 ± 8 mg% in hypertensives and 
36 ± 13 mg% in normotensive subjects, and the minimum blood 
glucose levels, 37 mg% in patients with hypertension and 
35 mg% in subjects with normal BP, were not significantly 
different (Fig. 4-4). The hypoglycaemia was associated with 
an increase in pulse rate and a fall in diastolic BP in
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both groups, and in the subjects with normal BP, a rise in 
systolic blood pressure (Fig. 4-4). The rise in adrenaline 
level in the hypertensive subjects was similar to that in 
normotensive subjects, 0.25 ± 0.13 ug/1 compared with 
0.22 ± 0.15 yg/1. Noradrenaline level did not change 
significantly (Fig. 4-5). There were small rises in PRA 
in both groups, + 0.22 ± 0.11 ng/ml/hr in the hypertensives 
and + 0.13 ± 0.30 ng/ml/hr in the subjects with normal BP.
The rise in PRA was statistically significant in 
hypertensives only (p < 0.05, paired t-test). Plasma 
volume increased with hypoglycaemia in both groups, from 
16.4 ± 1.5 cc/cm to 18.6 ± 1.7 cc/cm in normotensive subjects 
(p <0.05, paired t-test), but only marginally in 
hypertensives, from 17.2 ± 2.1 cc/cm to 18.2 ± 1.8 cc/cm 
(difference not significant).
Response to Mental Stress. There were significant 
rises in systolic and diastolic BP during mental stress in 
both hypertensive and normotensive subjects (p < 0.01,
Fig. 4-6). The rises were of similar magnitude in both groups. 
The urinary adrenaline level rose significantly, from 
0.06 ± 0.06 ijg/1 to 0.12 ± 0.06 yg/1 in both hypertensive 
and normotensive subjects (p < 0.05). There were no 
significant changes in noradrenaline level or PRA (Fig. 4-6).
Comparison of the Adrenergic Responsiveness of 
Hypertensives to the Different Stimuli. Among the 
hypertensive subjects, there was no tendency for the 
sympathetic hyperresponders to tilt, who had an enhanced 
noradrenaline response to this stimulus, to display larger
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than normal adrenaline responses to the other stimuli of 
hypoglycaemia and mental stress (Fig. 4-7).
DISCUSSION
In this study, a relationship was noted between reflex 
sympathetic nervous system responsiveness to tilting, and 
both the resting level of plasma renin activity and the renin 
response to tilting. Essential hypertensives exhibit 
a broad range of sympathetic nervous responsiveness when 
tilted, extending from the enhanced blood pressure and 
noradrenaline response of sympathetic hyperresponders, 
through to sympathetic underresponsiveness characterized by 
postural hypotension and negligible noradrenaline response 
(Fröhlich et al. , 1967; Chapter 3). The determinants of 
reflex sympathetic responsiveness to change in posture are 
incompletely understood, but response appears to be inversely 
related to the severity of the hypertensive disease 
(Chapter 3). Sympathetic hyperresponders to tilt were 
found to have elevated resting PRA levels and the largest 
rises in PRA with tilting, while patients with low-renin 
essential hypertension, characterized by a suppressed PRA 
level at rest and with stimulation, showed sympathetic 
underresponsiveness to tilting. Overall, there was 
therefore a close correlation between the renin and 
noradrenaline response to tilting.
There is strong evidence that the renin response to 
the upright posture is mediated through the sympathetic 
nervous system (Oparil et al. , 1970; Winer et al., 1969; 
Michelakis and McAllister, 1972). It is likely that 
differences in levels of PRA at rest, and renin
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responsiveness to tilting observed here were a consequence 
of differences in reflex sympathetic nervous activity in 
the hypertensive population studied. But another possible 
interpretation is that the relationship may be working in the 
reverse direction, through renin-angiotensin status influencing 
sympathetic nervous system activity. There is a considerable 
body of evidence supporting such a possibility, recently 
reviewed by Ferrario et al. (1972). Peripheral and central 
effects of angiotensin in enhancing sympathetic nervous function 
have been well documented in animals, and increased sympathetic 
responsiveness has been described in renovascular hypertension 
in man (Fröhlich et al. , 1967 (a)).
The reduced sympathetic responsiveness noted in low- 
renin essential hypertensives could possibly be the basis of 
the suppression of renin release which characterizes this 
disorder, but a more likely interpretation is that the 
reduced sympathetic and renin responsiveness both reflect 
retention of sodium, with the sympathetic nervous system 
having no primary role in determining renin status.
Sympathetic nervous activity is influenced by the level of 
dietary sodium in normal subjects, being greatest with 
sodium deprivation (Gordon et al. , 1967). Reduced 
sympathetic responsiveness has been described in primary 
aldosteronism (Biglieri et al. , 1962). Total body 
exchangeable sodium is increased in low-renin essential 
hypertension (Woods et al. , 1969) , and there is much 
indirect evidence implicating mineralocorticoid excess in 
the pathogenesis of this disorder (Crane et al. , 1972).
Both insulin-induced hypoglycaemia and mental stress 
were found to be poor stimuli for renin release. Although 
hypoglycaemia produced a large adrenaline response, of
similar magnitude in hypertensive and normotensive subjects, 
the rise in plasma renin activity was small, and statistically 
significant only in the hypertensives. Insulin hypoglycaemia 
has been shown to considerably elevate PRA in the dog 
(Otsuka et al. , 1970). The increase in plasma volume with 
hypoglycaemia may perhaps have been responsible for the 
smaller response observed in this study. With mental stress, 
blood pressure and urinary adrenaline excretion increased 
to a similar degree in hypertensive and normotensive subjects. 
These results are at a variance with those of Nestel (1969), 
who described an exaggerated blood pressure and catecholamine 
response to mental stress in borderline hypertension. In 
the present investigation, 8 of 10 subjects studied had 
sustained hypertension; the discrepancy in the findings may 
have resulted from the different composition of the groups 
studied. In both hypertensive and normotensive subjects, 
the stressful problem-solving procedure was without effect 
on PRA. The relative ineffectiveness of hypoglycaemia and 
mental stress as renin-releasing stimuli may be related to the 
fact that with both, unlike head-up tilting, the predominant 
catecholamine response involves adrenaline. From studies in 
the dog (Johnson et al., 1971), it would appear that 
adrenaline has no direct effect on renin release, the renin 
response with adrenaline resulting from a diminution in 
renal blood flow. In contrast, noradrenaline and renal 
sympathetic nerves have direct effects, independent of 
altered renal haemodynamics.
A subgroup of essential hypertensives has been described 
who display enhanced sympathetic nervous system and renin
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responsiveness to head-up tilting. Whether the larger 
posture-related rises in PRA and falls in GFR in these 
sympathetic hyperresponders are of pathogenic significance 
is not known. It was thought that with repeated stimulation 
by the upright posture, the larger changes in PRA and GFR 
might provide a potential mechanism for sodium retention and 
elevation of blood pressure. However, the acute reduction 
in urinary sodium excretion on tilting was no greater in this 
group than in other essential hypertensives. These tilt 
hyperresponders do not have a generalized sympatho- 
adrenomedullary overresponsiveness to adrenergic stimulation. 
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The effect of 25° head-up 
tilting on urinary sodium 
excretion in patients with 
essential hypertension.
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EVALUATION OF PRACTOLOL IN HYPERTENSION: EFFECTS ON
SYMPATHETIC NERVOUS SYSTEM AND RENIN RESPONSIVENESS
SUMMARY
The 3-adrenergic blocker, practolol, proved to be an 
effective antihypertensive agent in a single-blind 
crossover trial, involving 17 patients with essential 
hypertension of mild to moderate severity. After a 2-month 
placebo period, dosage was commenced at 100 mg bd, and 
titrated against blood pressure response up to a maximum 
dose of 400 mg bd, leading to an average reduction in BP 
of 20/18 mmHg, and satisfactory control in 14 of 16 patients 
(one defaulter). The clinical and physiological data were 
analyzed for prediction of response to practolol. The 
urinary noradrenaline response to head-up tilt, an index 
of the responsiveness of the sympathetic nervous system, 
correlated significantly with subsequent BP reduction with 
practolol 100 mg bd (r = 0.62, p < 0.01). In 8 patients, 
responsiveness to tilt was retested after control of the 
BP; changes in diastolic BP and pulse rate while on 
practolol were both significantly less than pre-treatment 
responses. The urinary noradrenaline response was also 
reduced (+0.50 yg/hr v s . pre-treatment mean of +1.64 yg/hr; 
p < 0.01), a finding not explicable in terms of known 
receptor-blocking properties of the drug. It is suggested 
that the antihypertensive action of 3-adrenergic blockers 
may be related to a reduction in the reflex activity of the 
sympathetic nervous system.
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Plasma renin activity, which was normal in the 
recumbent state, rose with tilting. The response with tilt 
was significantly reduced with practolol, although PRA 
during recumbency was only marginally lowered by the drug.
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INTRODUCTION
Although ß-adrenergic blocking drugs are finding 
increasing application in the treatment of hypertension, the 
mechanism by which they lower blood pressure remains 
uncertain. The antihypertensive effect has been attributed 
to a reduction in cardiac output (Fröhlich et al. , 19 68) , 
but a satisfactory reduction in blood pressure with oral 
medication has been stated to occur after a latent period 
of several weeks (Prichard and Gillam, 1969), whereas the 
effect on cardiac output is rapid. An unexplained 
phenomenon is the extreme range of sensitivity to the 
BP-lowering effects of ß-blockers shown by essential 
hypertensives, dose requirements of propranolol varying 
between perhaps 0.1 and 3 g daily (Zacharias, 1971;
Prichard, 1970).
Essential hypertensives exhibit a broad range of 
sympathetic nervous system responsiveness when subjected 
to postural stresses, extending from underactivity in 
patients responding to tilting with postural hypotension, 
through to increased activity in so-called "orthostatic 
hypertensives" who display greater than normal rises in 
blood pressure (Fröhlich et al., 1967) and noradrenaline 
(Chapter 3). The relationship between sympathetic 
responsiveness to change in posture and subsequent 
sensitivity to the BP-lowering effect of a ß-adrenergic 
blocker has been investigated.
Oral administration of propranolol produces a fall in 
blood pressure which is associated with a reduction in 
cardiac output, but total peripheral vascular resistance 
is increased (Fröhlich et al. , 1968). The relative
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contribution of reflex vasoconstriction and blockade of 
3-adrenergic vasodilator receptors in skeletal muscle to 
this rise in vascular resistance is not clear. The 
"cardioselective" ß-adrenergic blocker, practolol, has 
a lesser effect on vessels in skeletal muscle than 
propranolol (Barrett, 1971). This might be advantageous 
in the treatment of hypertension, and the efficacy of 
practolol as an antihypertensive agent has been assessed 
in the present study.
PATIENTS AND METHODS
Patients
The study was performed on 17 patients (8 male,
9 female), average age 38 years (range 21-56), with 
essential hypertension. All had sustained hypertension 
of mild to moderate severity. Average pre-treatment blood 
pressure was 164/107 mmHg (range 150/95 - 180/118), and 
severity index (Corcoran et al. , 1954) 2.5 (range 0 - 4.0). 
The diagnosis of essential hypertension was reasonably 
established by routine screening tests including urine 
microscopy and culture, serum and 24 hour urinary sodium 
and potassium, endogenous creatinine clearance, urinary 
catecholamines, and intravenous pyelography. None of the 
female patients was taking oral contraceptive drugs.
The majority of the patients had received no previous 
treatment for hypertension; 4 had been treated in the past, 
but not in the preceding 12 months. No patient with 
a history of bronchospasm, Raynaud's phenomenon, or cardiac 
failure was included in the study.
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Laboratory Investigations
Changes with tilting in blood pressure, urinary 
noradrenaline (corrected for changes in GFR) and plasma 
renin activity were measured. The experimental procedure 
was as follows: after an overnight fast, subjects were
rested supine in a single-bed ward for 90 minutes prior to 
the commencement of the study, at the end of which they 
emptied their bladder. Smoking was forbidden, and drinking 
water was given throughout to ensure an adequate urine flow. 
Then, after 90 minutes of recumbent rest, a timed urine 
sample was collected for assay of catecholamines and 
creatinine. Blood was drawn at this stage, after 3 hours 
of recumbency, for assay of serum creatinine and plasma 
renin activity. When blood pressure had stabilized after 
the venepuncture, the patients were tilted head-up at 25° 
on a tilt-table for a further 90 minutes. Blood pressure 
was measured at frequent intervals with a sphygmomanometer 
with the cuff at heart level. At the end of this period 
of tilt, further samples of blood and urine were collected 
for assay of catecholamines, creatinine, and plasma renin 
activity.
Urinary free noradrenaline and adrenaline were 
determined in duplicate using the method of Crout (1961) 
by differential fluorimetry using 2 sets of filters (von 
Euler and Lishajko, 1959).
Urinary creatinine was measured by a modification of 
the alkaline picrate method (Edwards and Whyte, 1958), 
serum creatinine by autoanalyzer.
Plasma renin activity was determined by the bioassay 
method of Skinner (1967) using the anaesthetized
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ganglion-blocked rat. The difference between 24 duplicate 
measurements of PRA was 6 ± 9% (mean ± standard deviation) . 
The assay was performed in duplicate on 2 different rats, 
and was repeated if duplicates differed by more than 24%
(mean difference + 2.S.D.).
Drug Trial Design
The antihypertensive effect of practolol was evaluated 
in a single-blind crossover trial in which a placebo was 
given for 2 months, followed by a fixed dose of practolol,
100 mg bd, for 6 months. The dose was then titrated against 
blood pressure response up to a maximum dose of 400 mg bd.
The pre-treatment BP value was the mean of 4 readings 
obtained from second-weekly outpatient attendances over the 
2 months on placebo. There was no fall in BP during this 
time. The treatment BP on the 100 mg bd dose schedule was 
the mean of all outpatient readings taken at intervals of 
2 to 3 weeks over the last 4 months of the 6 month period 
on practolol. If the recumbent BP exceeded 150/90 mmHg 
after 6 months, the dose was increased until the BP was 
reduced to this level, or until an arbitrary maximum dose 
of 400 mg bd was being given. Lying blood pressures 
were measured, by a single observer with a sphygmomanometer 
bag dimensions 30 x 12.5 cm, after 3-5 minutes of recumbent 
rest. Standing blood pressures were measured after the 
patient had been standing for 1-2 minutes.
RESULTS
The effect of practolol 100 mg bd on pulse rate and 
supine and standing blood pressures is shown in Table 5-1. 
Significant reductions in systolic and diastolic BP and
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pulse rate occurred on the drug. The falls in supine and 
standing pressures were of similar magnitude.
Practolol proved to be clinically effective as the 
sole antihypertensive agent in these patients with mild to 
moderately severe sustained hypertension. Using a recumbent 
BP of 150/90 mmHg as a therapeutic endpoint, in 7 of 17 
patients control was achieved with a dose of 100 mg bd, 
a further 5 required 200 mg bd, and another 2 patients 
400 mg bd. Since there was one defaulter, a dose of up 
to 400 mg bd resulted in satisfactory control in 14 of 16 
patients. At the upper dose level the mean reduction in 
recumbent BP was 20/18 mmHg.
The drug was well tolerated and in particular there 
were no recorded instances of postural or exercise-induced 
hypotension. A maculopapular rash, constipation, lethargy, 
and vivid dreams was each observed once, but did not require 
treatment to be stopped.
The rate of fall of BP on a constant dose of 100 mg 
practolol twice daily is shown in Fig. 5-1. In the 
7 patients who were controlled on this dose, the maximum 
fall in BP had virtually been attained by the time of the 
first outpatient attendance after 2 weeks of treatment 
(Fig. 5-1). There were no delayed falls in these patients, 
or in the others with smaller initial responses to this 
dose. On recommencing the placebo, the return of the BP 
to pre-treatment levels was slow, taking of the order of 
4 to 6 weeks (Fig. 5-1; BP 147/95 mmHg after 2 weeks off 
practolol vs . 162/102 mmHg after 6 weeks off practolol; 
p < 0.01 for paired t-test).
75.
Some essential hypertensives are very sensitive to 
the BP-lowering effects of 6-adrenergic blockers. We 
tried to categorize these retrospectively on clinical and 
physiological grounds. Some indices did not predict 
sensitivity to practolol. BP reduction on the low dose 
was unrelated to the initial level of the blood pressure 
(within the narrow range encompassed in this study), 
severity index, resting pulse rate, plasma renin activity, 
or the supplemental blood pressure (Smirk, 1954), (casual 
BP minus basal BP, a measure of the lability of the 
hypertension). The sympathetic responsiveness to head-up 
tilt did, however, correlate with subsequent BP reduction 
with practolol. When subjected to head-up tilt, essential 
hypertensives exhibit a broad range of sympathetic 
responsiveness, ranging from greater noradrenaline and BP 
responses than occurring in normotensive subjects through 
to normal or diminished responsiveness (Fröhlich et al., 
1967; Chapter 3). The hyperresponders to tilt, with 
greater than normal noradrenaline and BP responses, 
proved to be most sensitive to the BP-lowering effects of 
practolol at the lowest dosage. Overall there was 
a significant correlation between the urinary noradrenaline 
response to tilt and subsequent BP reduction (r = 0.62, 
p < 0.01; Fig. 5-2). The correlation between diastolic 
BP response to tilt and subsequent BP reduction on 
practolol was of a lower order (r = 0.42, 0.1 > p > 0.05), 
but "orthostatic hypertensives", with a diastolic BP rise 
of > 10 mmHg (Chapter 3), as a group had a larger fall in 
mean BP than the hypertensives with normal or reduced BP 
responses to tilt (fall in mean BP 23.1 ± 11.7 mmHg vs.
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10.8 ± 9.7, p < 0.05).
In 8 patients, in whom the BP had been satisfactorily 
controlled with either 200 mg (7) or 400 mg (1) daily, the 
responses to tilting were retested after an interval of 
9-24 months. The BP, pulse rate, and urinary noradrenaline 
responses were all significantly diminished (Fig. 5-3).
Five of these patients were recommenced on placebo, and 
after an interval of 2-3 months during which BP's rose to 
near pretreatment levels, responses were measured a third 
time. Tilt responses on placebo, including the 
noradrenaline response, were greater than on practolol, and 
had returned towards pretreatment figures (Fig. 5-3).
In 8 patients the effect of practolol on plasma renin 
activity was measured. PRA was measured after 3-4 hours 
of recumbent rest, and after 90 minutes of 25° head-up tilt, 
once before treatment, and again on practolol. There was 
no restriction of dietary sodium intake in these patients. 
Although big falls in unstimulated PRA occurred with 
practolol in the 3 patients in whom it was initially high, 
the difference overall was not significant at the 5% level; 
1.91 ± 0.46 ng/ml/hr (mean ± standard deviation) vs.
1.25 ± 0.34 on practolol; 0.05 < p < 0.1 paired t-test.
The PRA response to tilt was significantly diminished on 
practolol (Fig. 5-4; p < 0.01).
DISCUSSION
The antihypertensive effect of oral propranolol 
therapy is associated with a fall in cardiac output, but 
total peripheral vascular resistance is elevated (Fröhlich 
et al., 1968). Because practolol has much less activity
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on ß-adrenergic peripheral vasodilator receptors in 
skeletal muscle than propranolol (Barrett, 1971), and 
chronic oral administration of practolol is not associated 
with increase in total vascular resistance (Bodem et al., 
1971), it was anticipated that practolol too would lower 
blood pressure in essential hypertension, and perhaps be 
more potent in this regard than propranolol. In this trial, 
practolol proved to be an effective antihypertensive agent 
in patients with moderate sustained essential hypertension.
A similar finding has been reported by 2 other groups of 
workers (Prichard et al. , 1971; Waal-Manning, 1970). The 
antihypertensive activity relative to that of propranolol 
remains uncertain. In the only comparative trial (Waal- 
Manning, 1970), propranolol and practolol were found to be 
of similar potency, but since a 2-week crossover design had 
been used, a residual effect on blood pressure from the 
previous ß-adrenergic blocker may still have been present 
when the second drug was being evaluated.
As has been found previously with propranolol 
(Zacharias, 1971; Prichard, 1970), the essential 
hypertensive patients exhibited a broad range of 
sensitivities and hence dose requirements, although pre­
treatment blood pressures were similar. Sensitivity to 
the blood pressure lowering effect of practolol was 
unrelated to such variables as the resting pulse rate, and 
the supplemental BP, a measure of the lability of the 
hypertension. Only the sympathetic responsiveness to 
head-up tilt correlated with subsequent sensitivity to 
practolol. The haemodynamic and noradrenaline response 
to change in posture was used as an index of "sympathetic
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nervous activity". The urinary noradrenaline response 
is probably a qualitatively valid if quantitatively inexact 
index of change in sympathetic activity, and might reflect 
baroreceptor sensitivity, and the activity of central 
noradrenergic neurones and peripheral sympathetic nerves.
When responsiveness to tilt was reassessed in 8 patients 
on practolol (7 of whom had previously reacted as tilt 
hyperresponders), response in all was reduced to within 
the normal range. The fall in the noradrenaline response 
is not readily explicable in terms of known receptor­
blocking properties of the drug.
The mechanism by which practolol produced this 
reduction in reflex sympathetic activity is unknown. An 
increase in blood volume can reduce orthostatic 
responsiveness (Jeffrey et al., 1970). Blood volume was 
not altered by practolol in 3 patients in whom it was 
measured, and in fact, reduction in plasma volume with 
propranolol has recently been reported (Tarazi et al. , 1971). 
Although there is some indirect evidence of a reduction 
in baroreceptor sensitivity by propranolol in dogs (Booker 
et al. , 1969) , observations in man do not support this 
finding (Sleight et al. , 1971). An effect on central 
noradrenergic neurones is a possible explanation since the 
occasional side-effect of troublesome dreams (Wiseman, 1971) 
suggests that practolol enters the central nervous system. 
What relation, if any, this reduction in reflex sympathetic 
nervous system activity has to the antihypertensive action 
of the drug is uncertain, but it has often been suggested 
that repeated, greater than normal, reflex responses to
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pressor stimuli occurring in borderline hypertension may 
contribute to the genesis of sustained hypertension.
The search for the best existing drug for a particular 
patient with essential hypertension is largely a matter of 
trial and error. With ß-blockers, the main therapeutic 
guideline relates to the exclusion of certain patients, such 
as those with uncontrolled heart failure or a history of 
bronchospasm, there being no clear-cut grounds for preferring 
this class of drugs to another. Subgroups of patients with 
essential hypertension may exist who would be expected to be 
highly sensitive to ß-adrenergic blockers, such as those with 
"hyperdynamic ß-adrenergic disease" (Fröhlich et al. , 1969), 
in whom a raised blood pressure is associated with cardiac 
symptoms, such as palpitations, and excessive sensitivity 
to infused ß-agonist can be demonstrated. The orthostatic 
hyperresponders described in this study may prove to be 
another group in whome a ß-blocker might be a logical 
first line drug, although it is clear that with adequate 
dosage, satisfactory control can be achieved in the majority 
of hypertensive patients (Zacharias, 1971; Prichard, 1970).
It has been suggested that other physiological variables, 
such as plasma renin activity and cardiac output, may be 
relevant to the different sensitivity shown by individual 
hypertensive patients to ß-adrenergic blockers. While 
cardiac output was not measured, evidence exists that 
orthostatic hypertensives have a higher than average cardiac 
output (Fröhlich et al., 1967). In the present study, 
recumbent PRA before treatment did not correlate with 
subsequent BP reduction on the low dose of practolol.
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The effect of practolol on plasma renin activity is 
of interest. Unlike propranolol, which has been 
demonstrated to lower PRA (Stokes et al. , 1970), practolol 
did not significantly reduce recumbent PRA. However, the 
renin response to tilt was diminished by practolol. The 
sympathetic nervous system may be involved in the release 
of renin (Vander, 1967), including the renin release with 
upright posture (Winer et al. , 1969). The work in 
Chapter 4 suggests that renin responsiveness to head-up 
tilting is related to sympathetic nervous system 
responsiveness. The diminished renin response to tilt 
during practolol therapy may reflect only the diminished 
reflex sympathetic responsiveness.
TABLE 5-1
Mean Response to Practolol 100 mg b.d.
Placebo
Practolol 




Systolic BP (mmHg) 164 148 16 P < 0.001
Diastolic BP 107 94 13 P < 0.01
Pulse Rate/min 80 70 10 P < 0.05
Standing
Systolic BP 160 146 14 P < 0.01
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Figure 5-1. Average outpatient blood pressure, 
in 7 patients whose elevation of BP 
was controlled by a practolol dose 
of 100 mg twice daily, during 
intervals on (i) Placebo
(ii) Constant dose of practolol
(iii) Placebo. Means and standard 
errors are shown.
10 20 30
Reduction in Mean BP (mm hg)
with Practolol 100 mg b.d.
Figure 5-2. Relationship of pre-treatment urinary 
noradrenaline response to 25° head-up 
tilt in 17 patients with essential 
hypertension, to subsequent fall in 
Mean BP* produced by a practolol 
dose of 100 mg twice daily; 
r = +0.62, p < 0.01.
(* Mean BP = 1/3 systolic BP + 2/3 diastolic BP).
P re - tre a tm e n t Practolol Placebo
p1 p lacebo vs. practolol (pa ired  t - t e s t )  
p '' p laceb o  vs. p re - t r e a tm e n t
Figure 5-3. Average outpatient
diastolic BP and
responses in pulse
rate, diastolic BP, 
and urinary 
noradrenaline to 25° 




after control of the 
BP by practolol, and 
on return to a placebo. 
Mean values and 
significance levels 
(paired t-test) are 
shown.
jq / iu j/ß u -  o N in i l  H U M  A1IAI1DV 











































































THE EFFECT OF PRACTQLOL ON THE RELEASE 
OF RENIN BY ISOPRENALINE
SUMMARY
The effect of the 3-adrenergic blocking drug, practolol, 
on the heart rate and plasma renin responses to a graded 
isoprenaline infusion has been studied in normal subjects.
A dose of practolol which produced a 50-60% reduction in 
the heart rate response to isoprenaline was without effect 
on the renin response.
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INTRODUCTION
Reduced renin responsiveness to tilting was noted in 
essential hypertensive patients treated with the 
ß-adrenergic blocking drug, practolol (Chapter 5). Plasma 
renin activity (PRA) at rest was not significantly altered 
by long-term oral dosage of the drug. The responsiveness 
of the sympathetic nervous system to tilting was also 
reduced in these patients, providing a possible basis for 
the reduced renin responsiveness. An alternative 
explanation is that the reduced renin release may have been 
related to direct receptor-blocking properties of the drug. 
The acute effects of practolol on the release of renin by 
isoprenaline has been studied to investigate this second 
possibility.
The infusion of isoprenaline into normal dogs (Winer 
et al. , 1971), and dogs with experimental renovascular 
stenosis (Ayers et al. , 1969) , causes an increase in renin 
secretion. The renin response presumably results from 
direct effects of isoprenaline on juxtaglomerular cells, 
such as has been demonstrated with adrenaline and 
noradrenaline in vitro (Michelakis et al., 1969), and is 
unrelated to changes in arterial pressure and renal blood 
flow (Winer et al. , 19 71; Ayers et al. , 1969) . The 
renin response to isoprenaline is abolished by prior 
injection of propranolol (Winer et al. , 1971; Ayers et al. , 
1969) .
Practolol differs from propranolol in its range of 
action. Its receptor-blocking activity is mainly confined 
to 3-^-adrenoceptors of the heart (Barrett, 1971) . The
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direct effect of "relatively cardioselective" practolol on 
renin release has not been studied previously.
METHODS
The renin response to a graded infusion of isoprenaline, 
and the effect of a prior injection of 20 mg of practolol on 
this response, was studied in 5 normal subjects.
The subjects were healthy student volunteers, on an 
unrestricted diet. After an overnight fast, subjects were 
rested flat for 3 hours prior to commencing the test. A 
21 G scalp vein needle was inserted in an arm vein one hour 
before the first sample of venous blood was to be drawn, 
and the catheter kept open with a slow infusion of 0.9% 
saline. Isoprenaline was infused twice in each subject, 
the infusions being 2 days apart. One hour prior to 
commencing the infusion, either practolol 20 mg, or 10 cc 
of 0.9% saline was slowly injected intravenously, the order 
being randomized. Isoprenaline HCl (Winthrop) 
dissolved in saline, was infused with a Braun 
infusion pump at rates of 10, 20, and 30 ng isoprenaline 
base/Kg/min, each for 30 minutes (Fig. 6-1). 15 cc of
venous blood, for assay of PRA, was withdrawn via the 
catheter immediately before the injection of practolol or 
placebo, prior to commencing the infusion, and every 30 
minutes during the infusion. The blood was chilled then 
centrifuged, and the plasma frozen and stored at -20°C 
prior to estimation of PRA. Heart rate was measured at 
5-minute intervals during the period of infusion. The mean 
figure at which heart rate stabilized at each dose level was 
calculated. Blood loss from venous sampling throughout the
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study was 75 cc. This was replaced by approximately the 
same volume of 0.9% saline, amounting to 10 meq. of 
sodium, given over the total 3 % hours of the experiment.
Plasma renin activity was estimated by the bioassay 
method of Skinner (1967), using the anaesthetized ganglion- 
blocked rat.
RESULTS
The effect of practolol, 20 mg intravenously, on 
blood pressure, pulse rate, and PRA at rest is shown in 
Table 6-1. No changes were produced by the drug, including 
in PRA, which was 0.67 ± 0.26 ng/ml/hr (mean ± standard 
deviation) before practolol and 0.62 ± 0.21 60 minutes after 
practolol.
The changes in heart rate and PRA with isoprenaline, 
and the effect of practolol on these changes, are shown in 
Table 6-2 and Fig. 6-1. Isoprenaline produced increases 
in heart rate of 23 ± 4, 43 ± 8, and 61 ± 10 per minute at 
rates of 10, 20, and 30 ng/Kg/min respectively. After 
practolol, the corresponding increases in heart rate were 
11 ± 3, 18 ± 5, and 30 ± 3 per minute, equivalent to 
reductions of 52%, 58%, and 51% in the heart rate response 
to isoprenaline.
There were dose-related rises in PRA during the 
infusion of isoprenaline. Rises of 0.41 ± 0.23 ng/ml/hr 
(p < 0.05; paired t-test), 0.67 ± 0.35 (p < 0.01) and 
0.76 ± 0.31 (p < 0.01) occurred at infusion rates of 10,
20, and 30 ng/Kg/min respectively. After practolol, the 
corresponding rises in PRA were 0.28 ± 0.17 (p < 0.05),
0.51 ± 0.18 (p < 0.01), and 0.74 ± 0.17 (p < 0.01). The
increase in PRA produced by isoprenaline was not
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significantly different , with and without practolol, at 
any of the 3 rates of administration of isoprenaline.
DISCUSSION
In this study, isoprenaline was noted to increase 
peripheral venous PRA in man. There have been previous 
reports that isoprenaline increases the secretion of renin 
in dogs (Winer et al. , 1971; Ayers et al. , 1969). Infused 
adrenaline and noradrenaline (Michelakis and Horton, 1970) 
and catecholamines endogenously released during 
hypoglycaemia (Otsuka et al. , 1970), have been shown to 
increase PRA in man.
The mechanism by which sympathomimetic amines cause 
secretion of renin is not entirely clear. The relative 
importance of changes in arterial pressure, renal blood flow, 
and distal renal tubular sodium concentration, and direct 
stimulation of the juxtaglomerular cells, probably differs 
in relation to the particular agonist properties of the agent 
under consideration (Johnson et al. , 1971). From studies in 
the dog it would appear that the main effect of isoprenaline 
is a direct one on juxtaglomerular cells. The renin 
response to isoprenaline is unrelated to changes in arterial 
pressure and renal blood flow (Winer et al. , 1971), and the 
changes in renal tubule sodium concentration are such as to 
suppress rather than facilitate renin release (Gill and 
Casper, 1971).
A single dose of 20 mg practolol was found to reduce 
isoprenaline tachycardia by 50-60% at rates of infusion 
corresponding to approximately, 1, 2, and 3 yg per minute. 
Similar results have been reported by Brick et al. (1968).
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In the present study, the drug was given in a single dose, 
rather than by the cumulative-dose technique which is 
sometimes used. The half-time of practolol in man is 8-12 
hours (Fitzgerald and Scales, 1968). Since as Brick et al. 
(1968) had shown that the inhibition of isoprenaline-induced 
tachycardia by practolol was not related to dose in the 
range 5-20 mg, the single-dose technique was felt to 
adequately serve the aims of the study, which was to relate 
the effect of practolol on isoprenaline-induced renin release 
to the inhibition of the response in heart rate.
Unlike propranol, which lowers PRA at rest, and 
abolishes the rise in PRA produced by exogenous (Ayers et 
al., 1969) and endogenously released catecholamines 
(Assaykeen et al. , 1970), practolol was found to be without 
effect on PRA. PRA at rest, and the elevation in PRA 
produced by isoprenaline, were not influenced by the drug. 
From studies on the renin response to tilting (Michelakis 
and McAllister, 1972) and hypoglycaemia (Assaykeen et al. , 
1970), there is good evidence that 3-adrenergic mechanisms 
mediate in renin release, at least with these stimuli. As 
catecholamines have been shown to be capable, in vitro, of 
causing renin release (Michelakis et al. , 1969), and the 
effect of isoprenaline appears to be a direct one, it 
could be speculated that the failure of practolol to 
inhibit renin release produced by isoprenaline, and the 
ability of propanolol to suppress secretion in this setting, 
point to specific 6 2~a<3renoceptor mediation in the direct 
release of renin.
The evidence however is insufficient to sustain this 
argument. Although practolol has much less activity than
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propanolol against 32~adrenoceptors (Barrett, 1971), this 
is not the only major difference between the 2 drugs. For 
example, the 3n-adrenoceptor blocking activity of the 2 drugs 
is not identical; the effect of practolol on the heart is 
largely chronotropic, compared with the inotropic and 
chronotropic effects of propranolol (Finegan et al. , 1972). 
Further, the whole question of whether the release of renin 
by sympathetic nervous system stimulation or sympathomimetic 
amines is explicable in terms of classical receptor theory 
has been thrown open by the work of Winer et al. (1969, 1971). 
Findings of this group include blockade of the renin response 
to isoprenaline with phentolamine, suppression of the 
response to noradrenaline (predominant a-agonist activity) 
with propranolol, and abolition of the renin response to 
isoprenaline by d-propranolol. Cyclic AMP has been shown 
by these workers to stimulate renin secretion, this response 
being suppressed by both a- and 3-adrenergic blocking drugs 
(Winer et al. , 1971). These observations have been 
interpreted, not by reference to specific membrane receptors 
at cell surfaces, but rather in terms of intracellular 
actions of these agents distal to the generation of cyclic 
AMP. The longer half-life of practolol, and the fact that 
the majority of the drug is excreted unchanged in the urine, 
have been related to it having a lower lipid solubility than 
propranolol (Barrett, 1971). Reduced lipid solubility 
would perhaps prevent practolol from having an 
intracellular action on renin secretion such as that 
suggested for propranolol.
Whatever the basis of these anomalous findings, 
a failure of practolol to acutely inhibit renin release has
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been observed. This finding supports the contention that 
decreased renin responsiveness with long-term oral dosage 
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T IM E (min) ▲ Proctolol
• Placebo
Figure 6-1. The changes in pulse rate and plasma 
renin activity with isoprenaline in 
5 normal subjects, and the effect of 
practolol, 20 mg, on these changes.
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CHAPTER 7
HIGH CATECHOLAMINE ESSENTIAL HYPERTENSION;
CLINICAL AND PHYSIOLOGICAL CHARACTERISTICS
SUMMARY
Urinary catecholamine excretion has been measured in 
patients with sustained essential hypertension, borderline 
hypertension, secondary hypertension, and in subjects with 
normal blood pressure. The urinary noradrenaline level 
was elevated in approximately 25% of patients with 
sustained essential hypertension, but was normal in all 
patients with borderline hypertension and secondary 
hypertension. The relationship of elevated noradrenaline 
levels to certain physiological and clinical characteristics 
of essential hypertensives that might be related to 
increased catecholamine production has been investigated.
Of the characteristics studied, plasma volume, the 
responsiveness of the sympathetic nervous system, 
renin-angiotensin status, indices of emotional stress, 
and "hyperkinetic circulatory state", all proved to be 
unrelated to basal noradrenaline excretion. Urinary 
noradrenaline was related only to the level of the blood 




The possible role of the sympathetic nervous system 
in the genesis of essential hypertension has been widely 
investigated. Increased excretion of catecholamines in 
the urine in a proportion of patients with essential 
hypertension was an early finding (von Euler et al. , 1954) 
which has been confirmed in some (Nestel and Doyle, 19 68; 
Goodall and Bogdonoff, 1961), but not all (Crout et al. , 
1961) studies. The recent development of highly sensitive 
assays for catecholamines has led to the demonstration of 
elevated levels in plasma also (De Quattro, 1972; Engelman 
et al. , 1970). The significance of these higher levels 
in some hypertensives, and the underlying mechanism, remain 
uncertain, but studies by De Quattro (1971) with labelled 
noradrenaline precursor suggest that in these patients the 
release of noradrenaline is increased.
In recent years, attempts have been made to classify 
essential hypertension in terms of certain physiological 
and clinical characteristics. There have been reports of 
reduced plasma volume (Tarazi et al., 1968), low plasma 
renin activity (Jose and Kaplan, 1969), increased 
responsiveness of the sympathetic nervous system (Fröhlich 
et al. , 1967), and prominent cardiac symptoms in 
hypertensives with "hyperkinetic circulation" (Fröhlich, 
1971). Changes in catecholamine production, or altered 
responsiveness to secreted catecholamines, might 
theoretically be encountered with each of these. Plasma 
volume is reduced in phaeochromocytoma (Brunjes et al. , 
1960), and the secretion of renin and noradrenaline are 
related through a common response to salt depletion and
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hypovolaemia (Vander, 1967). Increased catecholamine 
production might occur in stress hypertension (Graham, 1945) 
accompanying chronic anxiety, or reflect the increased 
responsiveness of the sympathetic nervous system to 
adrenergic stimuli that has been reported in a proportion of 
patients with essential hypertension (Fröhlich et al. , 1967). 
Cardiac symptoms in hypertensives with "hyperkinetic 
circulation" might result from increased cardiac 
sympathetic nerve activity, or from high levels of 
circulating catecholamines.
In the present study, urinary free noradrenaline and 
adrenaline excretion has been measured in 35 patients with 
sustained essential hypertension (including 2 with malignant 
hypertension), 15 patients with borderline hypertension,
32 subjects with normal blood pressure, and 8 patients with 
secondary hypertension. The relationship of urinary 
catecholamine excretion to plasma volume, emotional stress, 
symptoms of "hyperkinetic circulatory state", responsiveness 
of the sympathetic nervous system, and renin-angiotensin 
status, has been assessed.
PATIENTS AND METHODS 
Essential Hypertensives
Fifty untreated patients were studied, 35 with 
sustained essential hypertension and 15 with borderline 
hypertension. Forty-one had never received treatment for 
the hypertension, while 9 had received some treatment in 
the past, though not in the preceding 12 months. The 
absence of recent treatment was related to the fact that 
all were either newly diagnosed, previously diagnosed
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defaulters, or patients with borderline hypertension. The 
blood pressure elevation was designated sustained 
hypertension or borderline hypertension on the basis of 
average casual, or 'usual' blood pressures (Julius and 
Schork, 1971), as outlined in Chapter 3. Secondary 
hypertension was reasonably excluded by routine screening 
procedures including urine microscopy and culture, serum 
and 24-hour urinary sodium and potassium levels, endogenous 
creatinine clearance, urinary catecholamine excretion, and 
in most cases intravenous pyelography (intravenous pyelo­
graphy was not carried out in 7 patients with borderline 
hypertension). Phaeochromocytoma was excluded by negative 
responses to tilting (Harrison et al. , 1967) and glucagon 
(Lawrence, 1967) in those subjects in whom further testing 
was indicated on the basis of urinary catecholamine levels. 
None of the female hypertensives was taking oral 
contraceptive drugs. The severity of the hypertensive 
disease was graded according to the scale of Corcoran et al. 
(1954). In 30 hypertensive patients it was felt that 
estimation of the duration of hypertension was possible, 
with adequate documentation from previous frequent medical 
examinations related primarily to employment. Duration 
was dated from the time that elevated pressure was first 
noted. The clinical diagnosis of "hyperkinetic circulatory 
state" (Fröhlich, 1971) was made in 11 patients with 
essential hypertension on the basis of significant 
discomfort related to unexplained recurrent cardiac 
irregularities and palpitations. In addition, some of 
these patients had an elevated resting pulse rate, and 
complained of tremor, anxiety and attacks of sweating.
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Thyrotoxicosis was excluded in this group. From the 
pattern of symptoms, and electrocardiographic evidence in 
most cases, the basis of the cardiac symptoms appeared to 
be sinus tachycardia in 8 patients, supraventricular 
tachycardia in 2, and multiple ventricular extrasystoles in 
one.
Patients with Secondary Hypertension
Of the 8 patients with secondary hypertension, 4 had 
oral contraceptive-induced hypertension, 3 had renal 
hypertension, and one had Cushing's syndrome. None had 
received treatment for the hypertension. In those with 
contraceptive-induced hypertension a family history of 
hypertension was absent and blood pressures were normal 
before commencing contraceptive therapy, but rose soon 
afterwards. Pressures fell to normal limits within 
12 months of stopping oral contraceptive therapy. Renal 
biopsy in the 3 patients with renal hypertension disclosed 
chronic nephritis in 2 and membranous glomerulonephritis 
in the third. A large adenoma of the right adrenal gland 
was found at operation in the subject with Cushing's 
syndrome.
Normal Subjects
The 32 normotensive subjects comprised 8 student 
volunteers, and 24 ambulant general medical patients drawn 
from a medical ward and its associated outpatient 
department. None of the patients was acutely ill, and 
most had been referred for diagnostic procedures. 
Experimental Procedure
The investigation was performed on the essential 
hypertensive patients as outpatients (29 subjects), or
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during the first 2 days of hospital admission (21 subjects), 
to minimize any effects of confinement and prolonged 
recumbency (Dietnck et al. , 1948) . Smoking was forbidden 
on the morning of the test. After an overnight fast, 
subjects were rested flat in a single-bed ward for 90 minutes 
prior to the commencement of the study, at the end of which 
they emptied their bladders. Then followed a 90-minute 
test period, during which patients were maintained 
recumbent. Drinking water was provided to ensure an 
adequate urine flow. Blood pressure was measured with 
a sphygmomanometer at 10-minute intervals, with 
disappearance of sound taken as the diastolic endpoint. 
Resting BP was calculated as the mean of the 3 lowest 
recordings. At the end of this period, blood was drawn 
for assay of serum creatinine and the subjects voided. The 
urine was acidified and frozen for future assay of urinary 
free catecholamines and creatinine. Urinary free 
noradrenaline and adrenaline were assayed in duplicate by 
a modification of the trihydroxyindole method (Crout, 1961) 
with differential fluorimetry using 2 sets of filters (von 
Euler and Lishajko, 1959). Internal standards were carried 
through the entire procedure. Urinary creatinine was 
measured by a modification of the alkaline picrate method 
(Edwards and Whyte, 1958) , serum creatinine was measured 
by autoanalyzer. From the serum creatinine concentration 
and urinary creatinine excretion, endogenous creatinine 
clearance was calculated. Urinary noradrenaline and 
adrenaline excretion was adjusted for within-group 
differences in GFR, and for incomplete emptying of the 
bladder, as follows:
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Adjusted catecholamine excretion (yg catecholamine/ 
litre of plasma cleared of creatinine) = catecholamine 
excretion (yg/min)/GFR(litre/min). As with the commonly 
adopted convention of expressing urinary catecholamines 
simply in relation to the rate of excretion of creatinine, 
the assumption is made that adrenaline and noradrenaline 
excretion is a function only of plasma levels and filtration, 
renal tubular mechanisms having no role. This remains 
unproven in man, and the evidence from animal experimentation 
is conflicting (Rennick and Pryor, 1965; Overy et al. ,
1967). Formal clearance studies in man are needed to 
clarify this point, but until definitive information is 
available, the adjustment of catecholamine excretion rates 
for differences in GFR would seem a satisfactory compromise. 
In 32 normal subjects a close correlation was observed 
between creatinine clearance and urinary noradrenaline 
excretion; r = 0.67, p < 0.001. All hypertensives studied 
but one (with normal catecholamine excretion) had a 
creatinine clearance of more than 80 ml per minute, so that 
discrepancies are not likely to have arisen through this 
adjustment.
In 18 subjects (10 male essential hypertensives, 8 male 
normal subjects) plasma volume was measured on the morning 
of the test using Evans Blue.
Psychometric Testing
Questionnaire-based psychometric testing was performed 
on 46 of the 50 patients with essential hypertension (mean 
age 37 years). Questionnaires used were the I.P.A.T.
Anxiety Scale Questionnaire (Cattell and Scheier, 1963) , 
which provides a measure of free-floating or manifest
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anxiety, and the Eysenck Personality Inventory, Form A 
(Eysenck and Eysenck, 1964) which measures 2 dimensions 
of personality, neuroticism-stability and extraversion- 
introversion. Scores were compared with those of a 
control group of 40 age-matched general medical patients 
(mean age 36 years).
Sympathetic Nervous System Responsiveness
The sympathetic nervous system responsiveness to 
head-up tilting was assessed in all patients with essential 
hypertension and in 11 subjects with normal blood pressure 
using the methods outlined in Chapter 3.
Renin Responsiveness
Plasma renin activity (PRA) was measured in all 
essential hypertensive and 12 normotensive subjects using 
the bioassay method of Skinner (1967). Blood was obtained 
for PRA twice: first, after the subjects had rested flat for
3 hours after an overnight fast, and again after 90 minutes 
of 25° head-up tilt.'
RESULTS
Urinary Catecholamine Excretion
The urinary adrenaline level was similar in all 4 groups 
(Fig. 7-1) with a level of 0.08 ± 0.07 yg/1 (mean ± standard 
deviation) in patients with sustained hypertension,
0.08 ± 0.05 yg/1 in patients with borderline hypertension, 
0.06 ± 0.03 yg/1 in patients with secondary hypertension, 
and 0.07 ± 0.06 yg/1 in subjects with normal blood pressure.
The urinary noradrenaline level of 0.29 ± 0.14 yg/1 in 
patients with sustained hypertension (Fig. 7-1) was 
significantly higher than the value of 0.20 ± 0.09 yg/1
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obtained in patients with normal BP (students t-test, 
p < 0.01). Noradrenaline in patients with borderline 
hypertension, 0.22 ± 0.09 ug/1, and secondary hypertension,
0.15 ± 0.07 ug/1, did not differ significantly from that 
of the normal subjects. Within the normal group, urinary 
noradrenaline level was similar in the volunteer and patient 
groups. In 8 of 35 patients with sustained hypertension, 
noradrenaline level was elevated, with values in excess of 
0.38 ug/1, corresponding to a noradrenaline level of more 
than 2 standard deviations above the mean value found in 
the normal subjects. In no patient with borderline 
hypertension was the noradrenaline level outside the normal 
range.
Total catecholamine level was 0.37 ± 0.18 ug/1 in 
patients with sustained hypertension, 0.30 ± 0.07 ug/1 in 
patients with borderline hypertension, 0.21 ± 0.11 ug/1 in 
patients with secondary hypertension, and 0.27 ± 0.13 ug/1 
in the normal subjects. Total catecholamine level was 
higher in patients with sustained hypertension than in the 
normotensive group (p < 0.02) solely due to the higher 
noradrenaline level.
Relationship of Catecholamine Levels to Blood Pressure
Urinary adrenaline level and the level of systolic 
and diastolic blood pressure were not significantly 
correlated in either the normotensive or essential 
hypertensive group (Table 7-1). In patients with 
essential hypertension there was a significant direct 
correlation between noradrenaline level and diastolic blood 
pressure (r = 0.44, p < 0.01; Fig. 7-2) and between 
noradrenaline and systolic blood pressure (r = 0.50, p < 0.001).
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In subjects with normal blood pressure, noradrenaline level 
was significantly correlated with diastolic blood pressure 
only (r = 0.41, p < 0.05; Table 7-1). Urinary 
noradrenaline and the severity index of the hypertensive 
disease showed a positive correlation (r = 0.39, p < 0.01; 
Fig. 7-3). There was no correlation between duration of 
the hypertension and noradrenaline level.
Plasma Volume
Noradrenaline level and plasma volume were unrelated 
in the 18 male subjects in whom plasma volume was measured 
(r = -0.06, N.S., Fig.- 7-4). Plasma volume was within normal 
limits in the 2 male essential hypertensives with elevated 
urinary noradrenaline.
Personality Testing
The I.P.A.T. Anxiety Scores in essential hypertensives 
and the control group of 40 medical inpatients were similar, 
28.6 ± 12.9- compared with 31.0 ± 13.9. In the hypertensive 
group there was no correlation between noradrenaline level 
and anxiety score. In the 8 patients with high urinary 
noradrenaline, the anxiety score was 26.2 ± 12.4, similar 
to the overall scores for hypertensive and control subjects.
The Eysenck neuroticism score of 10.1 ± 5.2 in 
essential hypertensives was not significantly different from 
that in the control group, 11.1 ± 5.4. Neuroticism score 
and noradrenaline level were unrelated, and the score of 
10.8 ± 5.5 in the hypertensives with high noradrenaline 
levels was within normal limits.
Adrenaline excretion also was unrelated to the anxiety 
and neuroticism scores.
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Sympathetic Nervous System Responsiveness
In response to 25° head-up tilt, in 11 normal subjects 
the increase in diastolic BP was 5.1 ± 3.4 mmHg, and in 
urinary noradrenaline excretion, 0.05 ± 0.05 yg/1. Fourteen 
of 50 patients with essential hypertension who showed a rise 
in diastolic BP of 11 mmHg or more, or an increase in 
urinary noradrenaline greater than 0.15 yg/1, in response to 
tilting, have been defined as "sympathetic hyperresponders" 
on the basis of rises in diastolic BP or noradrenaline above 
the range of responses observed in the normal subjects.
In 9 of these 14, both blood pressure and noradrenaline 
responses were above the normal range. Only one of these 
14 subjects with an enhanced sympathetic response to posture 
had an elevated resting noradrenaline level. In fact, 
response to tilting was higher in borderline and mild 
sustained hypertension than in severe hypertension, although 
overall the negative correlation between severity index and 
noradrenaline response was of low order and not significant 
at the 5% level (r = -0.28, 0.1 > p > 0.05; Fig. 7-3).
The resting noradrenaline level, in contrast, was higher in 
severe hypertension (Fig. 7-3) .
Renin Responsiveness
Plasma renin activity (PRA) during recumbency was 
1.25 ± 0.78 ng/ml/hour in essential hypertensives (excluding 
2 subjects with malignant hypertension) and 1.14 ± 0.38 
ng/ml/hour in normal subjects. There was no correlation 
between urinary noradrenaline excretion and PRA level at 
rest in either group. IRA in 7 subjects with elevated 
noradrenaline levels (excluding one with malignant hyper­
tension) was 0.94 ± 0.46 ng/ml/hour, which was similar to
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the overall mean in essential hypertension. PRA with 
tilting was 1.48 ± 0.41 ng/ml/hour in normotensives. Six 
of the essential hypertensives, with a PRA of less than 
0.66 ng/ml/hour after 90 minutes of 25° head-up tilt, had 
a renin level more than 2 standard deviations below the mean 
PRA during tilting in the normal subjects, and were 
categorized as "low renin essential hypertensives".
Resting noradrenaline level in these subjects was 0.25 ± 0.14 
yg/1, a value not significantly different from the overall 
mean in hypertensives, 0.27 ± 0.13 yg/1.
Hyperkinetic Circulatory State
In the 11 patients with unexplained recurrent 
palpitations in whom the clinical categorization of 
"hyperkinetic circulation" was made, noradrenaline level 
was 0.23 ± 0.07 yg/1 and adrenaline level was 0.08 ± 0.06 
yg/1. These values were similar to the overall means in 
hypertensives, 0.27 ± 0.13 yg/1 for noradrenaline and 
0.08 ± 0.06 yg/1 for adrenaline.
DISCUSSION
The previous finding of an increased excretion of 
catecholamines in the urine in a proportion of patients 
with essential hypertension has been confirmed in this 
study. The increase was confined to an elevated 
noradrenaline level in approximately 25% of patients with 
sustained essential hypertension, adrenaline excretion not 
differing from that in subjects with normal blood pressure. 
Adrenaline and noradrenaline levels were normal in patients 
with borderline hypertension. Adjusted mean total 
catecholamine level, expressed in relation to GFR in
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essential hypertensives was 0.35 ug/1 (ug/1 of 
catecholamines excreted per litre of plasma cleared of 
creatinine), and in subjects with normal BP was 0.27 ug/1. 
These figures compare with mean plasma total catecholamine 
levels of 0.35 ug/1 in essential hypertension and 0.27 ug/1 
in normal subjects recently reported by De Quattro (1972) 
using the sensitive plasma catecholamine assay of Engelman 
et al. (1968) , suggesting that adrenaline and noradrenaline 
may in fact be excreted passively by the kidney in man, 
and not subjected to the renal tubular mechanisms of 
secretion and reabsorption described in some other species 
(Rennick and Pryor, 1965; Overy et al. , 1967).
It has been suggested that the higher catecholamine 
excretion in a proportion of patients with essential 
hypertension might be a reflection of chronic emotional 
stress (De Quattro, 1971). Questionnaire-derived levels 
of anxiety and neuroticism were within normal limits in 
the patients with high urinary noradrenaline excretion.
That the higher catecholamine level is not a stress-induced 
phenomenon has not been entirely disproved as the 
psychological testing employed was directed at only 
a segment of total personality. However, if the 
hypertension is stress-related, it is not due to the 
interaction of stress with neurosis, nor is the stress- 
reaction manifest as a detectable anxiety state.
A proportion of patients with essential hypertension 
have a low plasma volume (Tarazi et al. , 1968). Enhanced 
responsiveness of the sympathetic nervous system to 
adrenergic stimuli such as head-up tilting can be 
demonstrated in approximately one quarter of essential
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hypertensives (Fröhlich et al. , 1967). Speculation that 
high catecholamine levels in essential hypertension might 
be the result of a noradrenergic response to hypovolaemia, 
or reflect enhanced responsiveness of the sympathetic 
nervous system, has not been confirmed. The resting 
urinary noradrenaline level proved to be related neither to 
plasma volume nor to the responsiveness of the sympathetic 
nervous system to change in posture.
Low-renin essential hypertension appeared to be 
unrelated to the pattern of catecholamine excretion. It 
was anticipated but not confirmed that noradrenaline levels 
might in fact be low in low renin hypertension, in which 
increased total body exchangeable sodium has been 
demonstrated (Woods et al. , 1969), as urinary catecholamine 
excretion is known to be related to sodium status, being 
highest in the presence of sodium depletion (Gordon et al., 
1967). Our results differ from those of Crane et al. (1972),
who have recently reported low total urinary catecholamine 
levels in low renin essential hypertension.
It was of interest that although cardiac sympathetic 
nerves are thought to contribute significantly to total 
catecholamine production and excretion (De Quattro and 
Sjoerdsma, 1968), adrenaline and noradrenaline levels in 
hypertensives with "hyperkinetic circulatory state" were 
similar to the overall mean figures for hypertensives.
This suggests that the symptoms may possibly arise from 
overresponsiveness to normal levels of catecholamines
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such as has been suggested by Fröhlich et al. (1969) in 
hypertensives with "hyperdynamic ß-adrenergic disease".
Of the clinical and physiological characteristics 
studied, the noradrenaline level proved to be related only 
to the level of the blood-pressure and to the severity of 
the hypertensive disease, subjects with severe 
hypertension having the highest noradrenaline levels. 
Although the release and excretion of noradrenaline is 
increased in essential hypertensives with high urinary 
catecholamine excretion (De Quattro, 1971), it seems 
unlikely that the modest elevations in noradrenaline 
levels observed in the present study could be the basis 
of large blood pressure elevations above the norm.
However, the estimation of urinary catecholamines is an 
insensitive index of sympathetic nervous activity, and 
circulating and urinary levels of noradrenaline may 
incompletely reflect the concentrations of neurotransmitter 
at sympathetic nerve endings.
An increase in catecholamine levels secondary to 
sustained elevation of the blood pressure is a possible 
explanation for which there is no supporting evidence. 
Catecholamine levels may be elevated in congestive cardiac 
failure (Chidsey et al. , 1962) , but none of our patients 
had any evidence of congestive failure. The mean 
noradrenaline level in patients with sustained secondary 
hypertension did not differ significantly from the urinary 
noradrenaline level in subjects with normal blood pressure, 
in contrast to the elevated mean noradrenaline level in 
patients with sustained essential hypertension, perhaps 
supporting a primary role for the noradrenaline elevation
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in the aetiology of essential hypertension. But 
interpretation of the lower noradrenaline level in these 
patients with secondary hypertension is difficult in view 
of the likelihood that there is sodium retention in these 
disorders.
TABLE 7-1
The Relationship of Urinary Adrenaline and 
Noradrenaline Excretion to Blood Pressure
Systolic BP Diastolic BP
Normal Subjects
Adrenaline r = + 0.13, NS r = + 0.32, NS






Adrenaline r = + 0.18, NS r = + 0.13, NS
Noradrenaline r = + 0.50, **•oIIU
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Figure 7-1. Urinary adrenaline and noradrenaline 
levels in patients with sustained 
essential hypertension, borderline 
hypertension, secondary hypertension, 
and in subjects with normal BP.
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Figure 7-2. The relationship between 
resting diastolic blood 
pressure and urinary 
noradrenaline level.
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NORADRENALINE EXCRETION 
DURING RECUMBENCY
CHANGE IN NORADRENALINE 
EXCRETION WITH TILTING
Figure 7-3. Resting urinary noradrenaline levels, 
and the increase with 25° head-up 
tilt, in patients with borderline 
hypertension (B), and in 3 grades of 
sustained hypertension (Grade I = 
Severity Index < 2.5, II = Severity 
Index 2.5 - 5.0, III = Severity 
Index > 5.0). Mean values and 
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Figure 7-4. The relationship between plasma 
volume and urinary noradrenaline 
level in 10 male hypertensive 
subjects and 8 male subjects with 




ANXIETY NEUROSIS AND INCREASED SYMPATHETIC NERVOUS 
ACTIVITY IN ESSENTIAL HYPERTENSIVES WITH SYMPTOMS
OF HYPERKINETIC CIRCULATION
SUMMARY
In a consecutive series of 54 patients with untreated 
essential hypertension, 14 patients had symptoms of 
hyperkinetic circulation including frequent tachycardia, 
palpitations, sweating and anxiety which suggested a possible 
diagnosis of phaeochromocytoma. Studies were carried out 
to determine whether these symptoms reflected intrinsic 
overactivity of the sympathetic nervous system which might 
be causally related to the hypertension or whether they 
were manifestations of anxiety. In one subgroup of 
6 subjects, psychometric testing indicated the symptoms 
were related to coexistent anxiety neurosis. A further 
6 subjects, with normal levels of measured anxiety and 
neuroticism, demonstrated a high resting pulse rate, 
elevated plasma renin activity, and increased responsiveness 
of the sympathetic nervous system to orthostatic stress. 
Whether the increased sympathetic nervous activity observed 
in this group is related causally to the cardiac symptoms 
and the hypertension remains uncertain.
106.
INTRODUCTION
Episodic palpitations, sweating, and tremor are 
symptoms common in phaeochromocytoma, and should suggest 
the diagnosis in any patient with hypertension. But the 
majority of hypertensive patients with such symptoms, when 
adequately investigated, prove not to have a catecholamine- 
secreting tumour. Significant discomfort related to 
recurrent cardiac irregularities, or rapid, forceful cardiac 
action, occurring without an obvious precipitant, or in 
relation to exercise or emotion, is a common complaint in 
these patients (Fröhlich, 1971). Findings reported in 
these hypertensives with "hyperkinetic circulation" 
include an elevated resting pulse rate and cardiac output 
(Fröhlich et at, , 1969) , enhanced responsiveness of the 
sympathetic nervous system and renin-angiotensin system to 
adrenergic stimulation (Kuchel et at., 1970), and increased 
sensitivity of the ß-adrenergic receptors of the heart to 
infused isoprenaline, in hypertensives with "hyperdynamic 
ß-adrenergic disease" (Fröhlich et at., 1969).
That hypertension with hyperkinetic circulation 
constitutes a distinct subgroup of essential hypertension 
is open to question. Elevated cardiac output, high resting 
pulse rate, and increased responsiveness of the sympathetic 
nervous system have been reported in borderline and mild 
sustained essential hypertension, in the absence of cardiac 
symptoms (Eich et al. , 1962; Fröhlich et at, , 1967). 
Further, it is well known that essential hypertension is 
commonly asymptomatic at the time of diagnosis, symptoms 
developing later in relation to anxieties induced by 
knowledge of the diagnosis and possible complications of
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hypertension (Pickering, 1972) . The symptoms described in 
hyperkinetic circulation are, in fact, non-specific, and 
similar to those found in neurocirculatory asthenia and 
anxiety states (Hurst and Logue, 1966).
The aim of the present investigation was to study the 
prevalence of symptoms of hyperkinetic circulation in 
a consecutive series of patients with untreated essential 
hypertension, and to investigate the relationship of these 
symptoms to levels of anxiety and neuroticism, and to the 
responsiveness of the sympathetic nervous system to 
adrenergic stimulation.
PATIENTS AND METHODS 
Essential Hypertensives
54 untreated patients were studied, 39 with sustained 
essential hypertension and 15 with borderline hypertension.
The blood pressure elevation was designated sustained 
hypertension or borderline hypertension on the basis of 
average casual, or "usual" blood pressure (Chapter 3).
Resting urinary catecholamine levels and sympathetic and 
renin responsiveness of most of these patients has been 
described, in another context, in earlier Chapters.
45 patients had never received treatment for the hypertension, 
while 9 had received some treatment in the past, though not 
in the preceding 12 months. The absence of recent treatment 
was related to the fact that all were either newly diagnosed, 
previously diagnosed defaulters, or patients with borderline 
hypertension. Secondary hypertension was reasonably 
excluded by routine screening procedures including urine 
microscopy and culture, serum and 24-hour urinary sodium 
and potassium levels, endogenous creatinine clearance,
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urinary catecholamine excretion, and in most cases 
intravenous pyelography (intravenous pyelography was not 
carried out in 7 patients with borderline hypertension). 
Phaeochromocytoma was excluded by negative responses to 
tilting (Harrison et at, , 1967) and glucagon (Lawrence, 
1967) in those subjects in whom further testing seemed 
indicated. None of the female hypertensives was taking 
oral contraceptive drugs.
The clinical diagnosis of "hyperkinetic circulatory 
state" (Fröhlich et al., 1969; Fröhlich, 1971) was made 
in 14 of these patients with essential hypertension.
These patients all had significant discomfort related to 
unexplained recurrent cardiac irregularities, or rapid, 
forceful cardiac action, occurring without an obvious 
precipitant, or in relation to exercise or emotion. In 
addition, some of these patients had an elevated resting 
pulse rate, and complained of tremor, anxiety, and attacks 
of sweating. Thyrotoxicosis was excluded in this group.
Subjects with Normal BP
Two groups of normotensive subjects were studied.
A consecutive series of 40 general medical patients from 
a medical ward and its associated outpatient department 
served as the control group for the psychometric studies.
A second series of 32 normotensive subjects, comprising 
8 student volunteers and 24 ambulant general medical 
patients, were the control group for the physiological 
studies. None of the patients in this second group was 




Urinary catecholamine excretion and plasma renin 
activity during recumbent rest, and the responsiveness 
of the sympathetic nervous system and renin-angiotensin 
system to change in posture, were measured.
Resting Plasma Renin Activity and Urinary Catecholamine 
Levels
The investigation was performed on all hypertensive 
subjects, 33 as outpatients, and 21 as inpatients, during 
the first 2 days of hospital admission, and on 32 
normotensive subjects. Smoking was forbidden on the 
morning of the test. After an overnight fast, subjects 
were rested supine in a single-bed ward for 90 minutes 
prior to the commencement of the study, at the end of 
which they emptied their bladders. Then followed 
a 90-minute test period, the subjects remaining recumbent. 
Drinking water was provided to ensure an adequate urine 
flow. At the end of this period, blood was drawn for 
assay of plasma renin activity (i.e. after 3 hours of 
recumbency), and serum creatinine, and the subjects voided. 
The urine was acidified and frozen for future assay of 
catecholamines and creatinine.
Sympathetic Nervous System Responsiveness
Sympathetic nervous system responsiveness to head-up 
tilt was assessed in all patients with essential 
hypertension, and in 11 subjects with normal blood pressure, 
by the methods used in Chapter 3. The resting urinary 
catecholamine level during recumbent rest, and the responses
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in diastolic blood pressure, pulse rate, urinary 
noradrenaline, and glomerular filtration rate to 90 minutes 
of 25° head-up tilt were measured.
Renin Responsiveness
Plasma renin activity (PRA) was measured in all 
hypertensive and 11 normotensive subjects using the 
bioassay method of Skinner (1967). All patients had been 
maintained on an unrestricted diet. Blood was obtained 
for PRA twice: first, after the subjects had rested flat
for 3 hours after an overnight fast, and again after 90 
minutes of 25° head-up tilt.
Laboratory methods
Urinary free noradrenaline and adrenaline were assayed 
in duplicate by a modification of the trihydroxyindole 
method (Crout, 1961) with differential fluorimetry using 
2 sets of filters (von Euler and Lishajko, 1959). Internal 
standards were carried through the entire procedure.
Urinary creatinine was measured by a modification of the 
alkaline picrate method (Edwards and Whyte, 1958), serum 
creatinine was measured by autoanalyzer. From the serum 
creatinine concentration and urinary creatinine excretion, 
endogenous creatinine clearance was calculated. Urinary 
noradrenaline and adrenaline excretion was adjusted for 
within-group differences in GFR, and for incomplete 
emptying of the bladder, as follows:
Adjusted catecholamine excretion (yg catecholamine/ 




Questionnaire-based psychometric testing was performed 
on 50 of the 54 patients with essential hypertension, and 
on the control group of 40 general medical patients with 
normal blood pressures. Questionnaires used were the 
I.P.A.T. Anxiety Scale Questionnaire (Cattell and Scheier, 
1963), and the Eysenck Personality Inventory, Form A 
(Eysenck and Eysenck, 1964) .
RESULTS
The 14 hypertensives with hyperkinetic circulation 
appeared to fall into 3 distinct groups (Table 8-1).
In six patients a diagnosis of anxiety neurosis could 
confidently be made. These subjects, all with anxiety 
scores of greater than 38 and neuroticism scores of 
greater than 14, had scores one standard deviation or more 
above the mean neuroticism and anxiety levels obtaining 
for the general population (Cattell and Scheier, 1963; 
Eysenck and Eysenck, 1964). In 2 patients cardiac 
stimulation seemed to be caused by exogenous pharmacological 
stimulation of the heart (Table 8-1). In one, it became 
apparent that symptoms were related to sinus tachycardia 
following the drinking of red wine. Symptoms occurred in 
no other context, and attacks were abolished when he 
stopped drinking. In the other, multiple ventricular 
extrasystoles seemed to be associated with a heavy 
consumption of coffee and tobacco. Symptoms and 
extrasystoles ceased when the patient stopped drinking 
coffee and smoking. The remaining 6 patients with 
hyperkinetic circulation, grouped purely on the basis
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of exclusion of other apparent causes, have been 
categorized as "sympathetic hyperresponders" (Table 8-1), 
for reasons to be described.
Hypertensives with Hyperkinetic Circulation and Anxiety 
Neurosis
The anxiety score in this group was 50 ± 3 (mean ± 
standard deviation), and the neuroticism score was 18 ± 2 
(Table 8-1). Anxiety and neuroticism levels were 
significantly higher than the levels in both the control 
group of general medical patients, 31 ± 14 and 11.1 ± 5.4, 
p < 0.01, and the hypertensive subjects without cardiac 
symptoms, 27 ± 13 and 9 ± 5, p < 0.001. The scores in 
these hypertensives with anxiety neurosis compare with 
scores of 46 for anxiety and 14.4 for neuroticism reported 
in 2 groups of patients, with a clinically significant 
anxiety state (Cattell and Scheier, 1963) and mixed 
neurosis (Eysenck and Eysenck, 1964) . 4 of these 6
patients had sustained hypertension, including 2 with 
hypertensive retinal changes and electrocardiographic 
evidence of left ventricular hypertrophy, making it 
unlikely that the elevation in blood pressure was simply 
a manifestation of an anxiety state. Sinus tachycardia, 
often with an emotional precipitant, was the basis of 
cardiac symptoms in all (Table 8-1). Associated symptoms 
such as sweating, anxiety, and tremor were common. In 
this group, the urinary catecholamine levels, resting pulse 
rate, and the sympathetic responsiveness to head-up tilt 
were within normal limits (Tables 8-2 and 8-3) .
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Sympathetic Hyperresponders
The 6 hypertensives with hyperkinetic circulation, 
without anxiety neurosis of drug-induced cardiac stimulation 
as an apparent cause of their symptoms, were categorized 
as "sympathetic hyperresponders". The basis of cardiac 
symptoms was paroxysmal supraventricular tachycardia in 
3, sinus tachycardia in 2, and multiple ventricular 
extrasystoles in one. Anxiety and neuroticism levels were 
within normal limits (Table 8-1), but associated symptoms 
of sweating, tremor, and anxiety were frequently noted, 
so that the clinical presentation of this group, apart 
from the higher incidence of supraventricular tachycardia, 
was similar to that of the patients with symptoms of 
hyperkinetic circulation and anxiety neurosis.
Additional findings were an elevated resting pulse rate 
(71 ± 9 per minute compared with 63 ± 7 in the subjects 
with normal blood pressure, p < 0.05; Table 8-2), high 
PRA (2.69 ±'1.18 ng/ml/hr compared with 1.09 ± 0.40, 
p < 0.001; Table 8-2), and an enhanced sympathetic 
responsiveness to head-up tilt (Table 8-3). The changes 
in diastolic BP, urinary noradrenaline, and glomerular 
filtration rate with tilting were all greater than those 
in the subjects with normal BP (p < 0.001, Table 8-3).
The increase in PRA with tilting, 0.56 ± 0.16 ng/ml/hr, was 
marginally greater than that in the control subjects,
0.33 ± 0.24, but the difference was not significant at the 
5% level (0.1 > p > 0.05).
Compared with the hypertensive patients without cardiac 
symptoms, this group had a higher PRA at rest (p < 0.001), 
and with tilting, larger rises in diastolic blood pressure
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(p < 0.001), pulse rate (p < 0.05), noradrenaline level 
(p < 0.01), and PRA (p < 0.05), and a greater reduction 
in glomerular filtration rate (p < 0.01) (Tables 8-2 and 
8-3) .
Hypertensives without Cardiac Symptoms
In these patients, the only difference from the 
findings in the subjects with normal BP was a higher 
resting urinary noradrenaline level, 0.28 ± 0.13 yg/1 
compared with 0.20 ± 0.09, p < 0.01.
Relationship of Onset of Symptoms to Time of Diagnosis of 
Hypertension
The mean time elapsed since diagnosis of the 
hypertension was similar in patients with and without 
cardiac symptoms, 4.3 years compared with 4.4 years 
(Table 8-1). In all hypertensives with anxiety neurosis 
and cardiac symptoms, symptoms preceded the diagnosis of 
hypertension. Overall among the hypertensives with 
hyperkinetic circulation, 10 of 14 had cardiac symptoms 
prior to the diagnosis of hypertension.
DISCUSSION
Although symptoms of episodic palpitations, sweating 
and anxiety in patients with an elevated blood pressure 
should suggest the possible diagnosis of phaeochromocytoma, 
most hypertensive patients with these symptoms do not have 
a catecholamine-producing tumour. Over the period of 
observation of the present study, 16 patients referred for 
work-up of hypertension presented symptoms of hyperkinetic 
circulation. 14 of these patients had essential
115.
hypertension, in a total of 54 patients finally diagnosed 
as having essential hypertension, and have been described.
Of the remaining 2 patients, one had thyrotoxicosis, and 
the other was the only case of phaeochromocytoma in the 
series.
The term "hyperkinetic circulation" has found wide 
usage in the literature on essential hypertension, but the 
meaning remains ill-defined and confusing. Symtomatology, 
physical findings, and haemodynamic findings have been 
used to differing extents by different authors in 
categorizing the syndrome. An elevated resting pulse 
rate, elevated cardiac output, and cardiac symptoms have 
all been emphasized (Julius et at. , 1971; Fröhlich, 1971) . 
The limits of the syndrome are not well defined, and the 
relationship of hypertension with "hyperkinetic circulation" 
to "neurocirculatory asthenia" (Hurst and Logue, 1966) and 
to the "hyperkinetic heart syndrome" (Gorlin, 1962) for 
example, is not clear. In the present study, the 
diagnosis of "hyperkinetic circulation" was made on the 
basis of the pattern of cardiac and associated symptoms. 
Cardiac outputs were not measured.
Essential hypertensives with hyperkinetic circulation 
were found not to constitute a homogeneous group.
Excluding 2 subjects in whom cardiac symptoms seemed to 
be provoked by extrinsic pharmacological stimulation, by 
red wine in one and coffee and nicotine in the other, the 
patients with hyperkinetic circulation fell into 2 groups.
In the first, with symptoms very similar to those of 
neurocirculatory asthenia, the presence of anxiety neurosis
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was demonstrated. The psychological disorder was 
presumably the basis of the symptoms. In all of these 
patients with anxiety neurosis, symptoms had preceded the 
diagnosis of the hypertension, and were not a result of 
anxieties raised by knowledge of the diagnosis and possible 
complications of hypertension. The elevated blood 
pressure recorded was not a temporary BP elevation 
accompanying an anxiety state, as 4 of the 6 patients in 
this category had retinal or electrocardiographic stigmata 
of hypertensive disease. The role of chronic anxiety 
in the aetiology of essential hypertension is an unsolved 
question (Gutman and Benson, 1971); the presence of both 
anxiety neurosis and essential hypertension in these 
patients may well have represented the coexistence of 
2 common, unrelated disorders. The concept of 
a "hypertensive personality" is difficult to support on 
current evidence (Gutmann and Benson, 1971).
In the second group of hypertensives with hyperkinetic 
circulation, no evidence of psychological abnormality was 
disclosed by the methods of testing used. These patients 
differed from the group with anxiety neurosis in having an 
elevated resting pulse rate, high plasma renin activity at 
rest, increased responsiveness of the sympathetic nervous 
system to change in posture, and by the occurrence of 
paroxysmal supraventricular tachycardia (in 3 of 6 subjects).
Adrenergic overactivity has been presumed to underly 
the symptoms and haemodynamic changes of hyperkinetic 
circulation (Fröhlich, 1971). An increased responsiveness 
of the sympathetic nervous system to one stimulus, that of 
change in posture, has been demonstrated in a proportion
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of our patients. Whether increased responsiveness to 
other adrenergic stimuli exists in these patients is not 
known. Greater than normal increases in adrenaline and 
noradrenaline excretion have been reported in borderline 
hypertensives exposed to mental stress (Nestel, 1969).
Cardiac sympathetic nerves are thought to contribute 
significantly to total noradrenaline production and 
excretion (De Quattro and Sjoerdsma, 1968). The high 
noradrenaline response to change in posture in the 
hypertensives with sympathetic hyperresponsiveness suggests 
increased cardiac sympathetic nerve activity as the 
possible basis of the symptoms, especially since cardiac 
symptoms in hypertensives with hyperkinetic circulation 
are said to be commonly posture-related (Fröhlich et at. , 
1969) .
The basis of the higher plasma renin activity at rest, 
a finding previously reported in patients with hyperkinetic 
circulation by Kuchel et al. (1970) is not clear. The
higher PRA may possibly be related to the increased 
sympathetic nervous responsiveness, as the sympathetic 
nervous system has been shown to play an important role in 
renin release (Vander, 1967). However this interpretation 
is not supported by the finding that the PRA response to 
tilting was only marginally higher in the sympathetic 
hyperresponders than in the subjects with normal blood 
pressure.
Noradrenaline excretion under resting conditions was 
significantly higher in the hypertensives without cardiac 
symptoms than in the subjects with normal BP. An
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elevated urinary excretion of noradrenaline at rest, in 
a proportion of patients with essential hypertension, has 
been observed in several studies (von Euler et at. , 1954; 
Nestel and Doyle, 1968). These patients tend to be the 
ones with the more severe hypertensive disease (Chapter 7). 
In this study, the hypertensive patients without cardiac 
symptoms had the highest mean severity index, higher than 
in the 2 groups of hypertensives with hyperkinetic 
circulation. The higher noradrenaline excretion at rest 
in the group of hypertensives without cardiac symptoms was 
presumably related to the disproportionately large number 
of patients with severe hypertensive disease it included.
A group of essential hypertensive patients with 
symptoms of hyperkinetic circulation, raised heart rate, 
increased sympathetic nervous responsiveness, and high 
plasma renin activity has been delineated. Whether this 
is in any sense an aetiologically distinct and separate 
























t3 in ■ p
(DOW
in C C 
ft cp ai —
CO
rH VO in
(0 io x  in
X -P  P  p  





0) <D > ,  >i 
















































































































P  0) cn
r o x  a)
U f t  P  X
>1-P 10 o*
u  i t  «  P  X 










































t P d t x x  
x  P  p  3  in
C  i t  i t  U >i
i i  D ü  -P in 
>  >1 >1 P  ITS
(0 X  X  X  p










f t  <0 10 V  X  
3  x  X  >  0)























































































X C T3 -P
O -P a) in
X  C C
O P  -P ID
•P 11 O  10 X  
X  T3 X  X  P  
io p  in <u 
X  0  3 f t






















rH VO in 00 VO











X U  O
X P P
-P  -P  3
J U  u
cn u
O ‘P  >i
> X X
• H O )  (1)
W C H
C -H X
a) x  c
x  p  <
p a) 
a) a  







tn x  
C 3 










P> 0)tu a) 
x  P 
x  P<o a> 






oo Z  QL)
ft
E
X 3 x  in
&



















u a  c  3 a) o 
p p 
a) cp 
x  x  










X ft in >, 
ai x  
x








• X o 
TJ W X 
0) X
W X T3 
•P a) C 
X  >  fO 
0)
a) x  ft 
p x
10 <o 
u x  
w e m  
C (0 E 
O O P  
•P -P o 
X X c 
(0 -P 
•PCX 
> CP X 
a) -p p 
V  <n 3
O  O «1 
p X X
10 u
T> P <D 
C (I) -n 
<0 X X
x a) 3in p in 
o n e
C M -P 
(0 in 
•p in 
in p a; 
c a) 3 
3 x  x
Q) «1 10



































































-H — co 00 CO o
G >i P CO H CO
0  4-1 A • • • •
Dh -h  \ o H o o
>  rH
«3 -H 6 4-1 41 41 41
£  4-> \
03 O O' i—1 ac 00 CTC
G <  G O CO H O
rH • • • •
(X H CM H H
d) r-.
4-1 G
fO -H 4C O
«  g <J\ CTC H r~
a  p 41 41 41 41
03 d)
rH &, r - H CO







0 O O o O
G • • • •
03 -H o O o o
rH H
0  (13 41 41 41 41
>  G
0  0 CT\ m 00 r -
XI P O o O o
TJ • • • •





H  G 4c
O -H in 00 CO OC
X  H o o H o
Ü «3 • • • •
d) G o o O o
-P d)
«3 P 41 41 41 41
<J T3
«3 CM CM 00 O
> i P CM CM CM CM
P  O • • • •








d) CO CO o CM
















>1 U P CO 03
p ■H d) 0
O -P T3 u P
tP 0 G «3 04
d) G 0 •H
-P •H a 'O
«3 X 03 P o
U P d) «3 0
0 p u H
O Or p CQ
-H rH 05 0 A
4-> X •H 04 G H
03 05 >1 0 «5
O A 0 X X g
C -P P A P
CP •H G o •H 0
«3 2 0 -H 2
•H 2 4-1
Q 05 0 03 X
0 rH X 0 A
> 4-1 A > -H
■H 0 «3 -H
03 -H 04 03
C X £ G 03
0 G >4 d) A
-P < CO A O
P P 0
d) d) • n
C4 04 X































































































4-> v  
G
d5 0  ^



















■H 0  
G 4-1 
tP P  
•H 0  
05
rH
0  X  
4->
0 
P  A  
0  -P 
44
0  G 
P  -H
05 0  
X  05 
05 0  
•H A  



















c CD CD rp p
•p o rH CO CN
G G P • • • •
•P 0) > iX O o o o
K P  \
(L) *H rH + 1 +1 +1 +1
CP 03 > g
g e -p \ P* CD m ro
03 03 P  CP P- in CN ro
X  03 U C • • • •
CJ -H <  — o o O o




o o r-~ CO
0) X rH rH rH rH
CMP <#>
C O - +1 +1 + 1 + 1
03
X CD CP 00 I"






G -P r~ 00 rH m
•P ip i—l o o rH o
P 03 ^ • • • •
0) 03 C rH o o o o
CP G 03 \
C -P  P O' +1 +1 +1 +i
n p f l  a
X D  o l - CP CN r-~ m
CJ P o CM o o
0 • • • •
2 o o o o
+ + + +
<13 — o ro
C P C • • •
-P 03 -P p* in m CD
«  g
03 +i +i +i +1
CP 03 P
G 03 03 r- p* p* mos p  a • rH • •
X  G ~ CP + 00 CP




•P C3 ~ r~ CN p p
•P CP • • • •
03 rp EC in ro CD ro
CP O g
g p  e +i +i +1 +i
05 03 '—
X  03 00 p m rH






• -r—i CD CO o rH















>i o P >1 03
P •p 03 CO 0)
0 p X) P
CP 03 G o 04
03 C 0 03
P •P X •P 73
03 03 73 0
CJ P 03 P 0
03 P 03 rH
o X P CJ m
•p Ep 03 03
p EC -P X P rH
03 03 >i G
0 X 0 X 0 g
G P P X P
CP ■P G Ü P o
03 £ 0) •p •P 2
•P 2 p £a 03 03 X
03 >. X 03 P
> P P > •P
•P 03 03 •P •s
03 -P X 03
c X 6 G 03
0) c >i 03 P






























































































P  o  
o
03 •





























In this thesis, resting and reflex activity of the 
sympathetic nervous system has been studied particularly 
with respect to the pathogenesis of hypertension. The 
release of renin and the antihypertensive activity of the 
ß~adrenergic blocking drug, practolol, have been studied 
from the point of view of their relationship to the reflex 
activity of the sympathetic system. Sympathetic nervous 
system responsiveness has been assessed by studying the 
changes in blood pressure, urinary noradrenaline excretion, 
and glomerular filtration rate elicited by stimuli such as 
changing posture. Quantitative interrelationships have been 
observed between the increments in diastolic BP and urinary 
noradrenaline, and the fall in GFR with head-up tilting 
(Chapter 3). The mean responses in the hypertensive group 
studied were similar to those in subjects with normal blood 
pressure. Some hypertensives, however, were underresponsive 
to tilting, with small changes in diastolic BP, noradrenaline 
level and GFR, while approximately one quarter of essential 
hypertensives, categorized as "orthostatic hyperresponders", 
had larger rises in diastolic pressure and noradrenaline 
and a larger fall in GFR with tilting than occurred in the 
normotensive subjects. When these hyperresponders were 
retested, a high degree of reproducibility could be 
demonstrated over an interval of up to 2 years (Chapter 3). 
This is similar to the experience of Fröhlich et al. (1967).
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1. Hyperresponsiveness to Tilt.
The clinical correlates of sympathetic responsiveness to 
tilting have been outlined in Chapter 3. An inverse 
relationship was noted between responsiveness to tilting and 
both the severity and the duration of the hypertension.
As a group, the tilt hyperresponders had borderline or mild 
sustained hypertension, and tended to be young, with recent 
onset of the hypertension. Six of 14 had symptoms of 
hyperkinetic circulation (Chapter 8).
The basic mechanism underlying an enhanced response is 
not known. The published work on baroreceptor sensitivity 
in essential hypertension provides no evidence to 
suggest that the increased reflex responsiveness could arise 
at this level: baroreceptor sensitivity is if anything
reduced in mild hypertension (Bristow et al. , 1969). The 
possibility of disturbed function at other levels, such as 
in relation to the central integration of sympathetic 
function, or involving the nerve terminals, has not been 
investigated. These tilt hyperresponders do not have 
a generalized sympatho-adrenomedullary overresponsiveness to 
adrenergic stimulation. Their catecholamine responses to 
the other stimuli tested, hypoglycaemia and "mental stress", 
were within normal limits (Chapter 4). As adrenergic 
overresponsiveness was therefore confined to change in 
posture, the possibility was entertained that the enhanced 
sympathetic responsiveness to upright posture was directly 
related to the pathogenesis of the hypertension, rather than 
merely reflecting a generalized sympathetic overresponsive­
ness. Some findings reported in this thesis support this 
contention, but the evidence is indirect and incomplete.
121.
The first line of evidence relates to the possibility 
that there may be a posture-related retention of sodium in 
the tilt hyperresponders. These patients had larger falls 
in glomerular filtration rate and larger rises in plasma 
renin activity with tilting than subjects with normal BP 
(Chapter 3, Chapter 4), providing a potential mechanism for 
sodium retention and elevation of blood pressure. Sodium­
loading in sensitive animals, such as the partially 
nephrectomized dog (Coleman and Guyton, 1969), leads to 
an elevation in cardiac output and arterial pressure. 
Fröhlich and associates (1967) have reported cardiac output 
to be higher in orthostatic overresponders than in 
hypertensives with a normal or reduced response to tilt.
The acute effects of tilting on urinary sodium excretion, 
however, were not in accord with this line of reasoning: 
the mean reduction in urinary sodium excretion with tilting 
was no greater in tilt hyperresponders than in normally 
reacting hypertensives (Chapter 4).
A second line of evidence suggesting that an enhanced 
sympathetic response to upright posture may be the mechanism 
by which a sustained elevation of the BP is produced in 
some hypertensive patients derives from studies with the 
3-adrenergic blocking drug, practolol (Chapter 5). This 
drug proved to be an effective antihypertensive agent in 
the majority of patients in doses of up to 800 mg daily. 
However at low doses, the BP was lowered significantly more 
in the tilt hyperresponders than in other hypertensives.
In the orthostatic overresponders, the fall in BP to normal 
levels with practolol was associated with a reduction in the 
sympathetic response to tilt, also to within normal limits.
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Both these lines of evidence are very indirect. The 
enhanced response to tilting in some hypertensives may well 
reflect only increased sympathetic nervous activity which 
is secondary to other, possibly more important factors, such 
as altered renin-angiotensin status (Chapter 4).
2. The Effect of Practolol on Sympathetic and Renin
Responsiveness.
The ß-adrenergic blocking drug, practolol, has been 
evaluated as an antihypertensive agent in patients with 
essential hypertension (Chapter 5). As indicated, the blood 
pressure fall produced by a low dose of the drug proved to 
be related to the previously assessed level of sympathetic 
nervous system responsiveness to tilting. When the 
responses to tilt were retested during practolol therapy, 
they were found to be reduced. In the tilt hyperresponders, 
the responses were reduced to within normal limits by 
practolol, to return to pretreatment levels when the drug 
was stopped. The renin response to tilting was also 
reduced in patients taking practolol, although the resting 
level of PRA was not significantly changed. Practolol 
seems to have no direct effect on renin release (Chapter 6). 
As a close relationship existed between the sympathetic 
and renin response to tilt in untreated hypertensive 
patients (Chapter 4), it is likely that the reduced renin 
response noted with practolol therapy reflected the 
diminished reflex sympathetic activity in patients taking 
the drug, rather than resulting from a direct effect of 
practolol on renin release.
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The predominant mechanism by which 3-adrenergic blocking 
drugs lower BP is not known. Although a fall in cardiac 
output occurs with long-term oral dosage of 3-blockers 
(Fröhlich et al. , 1968), this does not appear to be the 
major antihypertensive mechanism (Tarazi and Dustan, 1972).
A reduction in reflex sympathetic and renin responsiveness 
with practolol has been reported here. While it is not 
clear whether this could lead to a sustained lowering of 
blood pressure in essential hypertension, it does represent 
a possible mode of action for these drugs.
3. The Relationship of Sympathetic Nervous Responsiveness
to Renin Release.
In Chapter 4, a positive correlation between the 
responses in urinary noradrenaline and plasma renin activity 
to head-up tilting was reported in patients with essential 
hypertension. This is consistent with the known role of 
the sympathetic nervous system in mediating renin release 
(Vander, 1967). "Tilt hyperresponders" had a greater 
renin response than either normotensive subjects or other 
hypertensives. A corollary finding was that sympathetic 
responsiveness to tilting was reduced in patients with 
low-renin essential hypertension.
Hypertensive patients with a small sympathetic and 
renin response to tilting appeared to fall into 2 categories. 
One group, the low-renin hypertensives, had low PRA at rest, 
and a small renin response to tilt. In the second group,
PRA at rest was within normal limits, but sympathetic and 
renin responses to tilt were diminished. Sympathetic 
responsiveness to tilting was related to the severity of 
the hypertensive disease (Chapter 3). By and large, the
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members of this second group, with a normal PRA level at 
rest, had severe hypertensive disease. Of the 6 patients 
with low resting PRA., 5 had borderline or mild sustained 
hypertension only. Sympathetic underresponsiveness was 
therefore found in 2 situations: firstly, in patients with
severe hypertensive disease, together with a reduced renin 
response to tilt, but normal PRA at rest, and secondly, in 
patients with low-renin hypertension, in whom PRA was 
reduced both in response to tilt and at rest. In the low- 
renin hypertensives, the findings could possibly be related 
to an increased total body sodium content, since PRA at 
rest, and sympathetic and renin responsiveness to the 
upright posture are all reduced in primary aldosteronism 
(Biglieri et al. , 1962).
4. "High Noradrenaline Essential Hypertension".
The previous finding of an increased excretion of 
catecholamines in the urine in a proportion of patients with 
essential hypertension (von Euler et al., 1954; Nestel and 
Doyle, 1968) has been confirmed (Chapter 7). The increase 
was confined to an elevated noradrenaline level in 
approximately 25% of patients with sustained hypertension. 
Noradrenaline excretion at rest was normal in patients with 
borderline hypertension. No relationship was observed 
between resting noradrenaline excretion and certain 
physiological and clinical characteristics of essential 
hypertensives that might be related to increased catecholamine 
production, such as plasma volume, reflex sympathetic 
activity, renin-angiotensin status, and levels of anxiety. 
Urinary noradrenaline excretion was related only to the
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level of the blood pressure, being highest in patients with 
more severe hypertensive disease.
Total peripheral vascular resistance is also elevated 
in patients with more severe hypertension (Bello et al. , 
1967). A neurogenic basis for the elevated TPR in these 
patients with severe disease would be the simplest 
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